Document:

<Page>

                                                                Exhibit 10.12

Portions of this exhibit have been omitted pursuant to a request for
confidential treatment filed with the Securities and Exchange Commission. The
omissions have been indicated by asterisks ("*****"), and the omitted text has
been filed separately with the Securities and Exchange Commission.

             CLEARING 21-REGISTERED TRADEMARK- SOFTWARE MARKETING
                           AND DISTRIBUTION AGREEMENT

                                   RESTATEMENT
                   EFFECTIVE THIS 30TH DAY OF JANUARY, 2001

BETWEEN

SOCIETE DES BOURSES FRANCAISES, and its successor, Euronext-Paris, a corporation
organized and existing under the Laws of France duly registered with the Trade
Registry of Paris under number B 343 406 732 and having its registered offices
Palais de la Bourse, Place de la Bourse 75002 PARIS, and having its principal
office 39, rue Cambon 75001 PARIS, duly represented by its Chairman and Chief
Executive Officer, Mr. Jean-Francois Theodore.

            (Hereinafter referred to at times as "SBF" or "Licensee"),

AND

CHICAGO MERCANTILE EXCHANGE, a not for profit corporation organized under the
laws of the State of Illinois and having its principal office situated at 30
South Wacker Drive, Chicago, Illinois 60606 U.S.A., and its successor, Chicago
Mercantile Exchange Inc., a Delaware for-profit company, duly represented by its
President and Chief Executive Officer, Mr. James J. McNulty,

           (Hereinafter referred to at times as "CME" or "Licensor"),

AND

NEW YORK MERCANTILE EXCHANGE, a New York corporation having an office at One
North End Avenue, World Financial Center, New York, New York 10282-1101
U.S.A., and its successor, New York Mercantile Exchange Inc., a Delaware
for-profit company, duly represented by its Executive Vice President, Mr.
Neal Wolkoff.

            (Hereinafter referred to at times as "NYMEX" or "Licensor").

                                       1

<Page>

                                    RECITALS

      WHEREAS, Licensors, as hereinafter defined, have developed, jointly own
and separately operate for their respective markets, a computerized system of
clearance and settlement for derivative instruments commonly referred to as
"CLEARING 21", with respect to which Licensors hold, or have applications
pending for, trademarks registered in the United States of America and
elsewhere.

      WHEREAS, CME requested and received NYMEX's approval to include the
CLEARING 21 system in an exchange of technology by CME with SBF that occurred on
June 5, 1997 (collectively, the "June Technology Swap"), which approval was
granted in a letter dated May 15, 1997 from Mr. Rappaport to Mr. John F.
Sandner.

      WHEREAS, as part of the June Technology Swap, CME granted SBF a CLEARING
21 software license for use in connection with SBF's own internal business
purposes (the "June CLEARING 21 License"), and SBF granted CME corresponding
license privileges with respect to certain electronic trade entry software
developed and owned by SBF.

      WHEREAS, Licensors have agreed to authorize a sublicense of the Clearing
21 Software License Agreement to Clearnet, as permitted in the original
agreement without additional consideration, contingent upon, and to become
effective simultaneously with, this Agreement.

      WHEREAS, Licensors and SBF entered into the original CLEARING 21 License
and Software Marketing and Distribution Agreement to promote CLEARING 21 as a
global standard for clearing and settlement of financial products and to advance
their mutual interest in promoting, marketing, licensing, sublicensing and
providing training and maintenance to prospective third party users of CLEARING
21.

      WHEREAS, Licensors and SBF have agreed to restate the terms of the
original CLEARING 21 Software Marketing and Distribution Agreement as follows:

      NOW THEREFORE, in consideration of the premises and the mutual promises
and undertakings herein expressed, Licensors and Licensee hereby agree as
follows:

                           ARTICLE 1 - INTERPRETATION

      1.1.  DEFINITIONS.

      In this Agreement, unless the context otherwise requires:

      (a)   "Bilateral Agreement" shall have the meaning set forth in Section
8.3.

      (b)   "CLEARING 21" shall have the meaning set forth in the Recitals.

                                       2

<Page>

      (c) "CLEARING 21 Base Product" means the CLEARING 21 computer software
modules, including the source code and object code therefor, and any manuals,
technical specifications and/or other forms of documentation pertaining thereto,
whether embodied in printed, electronic or any other type of format, as
developed, modified or enhanced from time to time by or for a Licensor; or by or
for another entity, not itself a party to this Agreement, pursuant to a separate
CLEARING 21 license agreement entered into by a Licensor or Licensee in which
such Licensor or Licensee is permitted by the terms of such license agreement to
relicense and redistribute such computer software modules and related
documentation. For purposes of this Agreement, the CLEARING 21 Base Product
shall include, but shall not be limited to, the following computer software
modules: Product, Organization and Account, Position Management, Performance
Bond, Settlement, Asset Management and Banking, Exception Risk, Currency,
Calendar, Security and Execution Control.

      (d)   "DEC" shall have the meaning set forth in Section  5.3.

      (e) "DEC Enhancements" shall have the meaning set forth in Section 5.3.
The modules comprising the DEC Enhancements constitute a portion of the CLEARING
21 Base Product for which a Prospective User shall be required to obtain a
separate sublicense or sublicense upgrade.

      (f) "Derivative Work" means any computer software module, including the
source code and object code therefor, and any manuals, technical specifications
and/or other forms of documentation pertaining thereto, whether embodied in
printed, electronic or any other type of format, that is based upon or derived
from the CLEARING 21 Base Product or any part thereof and is created: (a) by,
for, or under the direction of Licensee in accordance with the license granted
to Licensee by Licensors hereunder, or (b) by, for, or under the direction of a
Sublicensee in accordance with the terms of a sublicense agreement entered into
with Licensee.

      (g) "Derivatives Product" means a financial product or contract whose
market value is based upon or derived from some other, underlying value,
including, without limitation, a futures contract, options contract, forward
contract, swap agreement or other similar type of instrument.

      (h)   "Intellectual Property Claim" shall have the meaning set forth in
Section 7.5.

      (i)   "June CLEARING 21 License" shall have the meaning set forth in
the Recitals.

      (j)   "June Technology Swap" shall have the meaning set forth in the
Recitals.

      (k) "Licensor" means CME and NYMEX, severally. In the plural voice, the
term means CME and NYMEX, jointly and severally.

                                       3

<Page>

      (l) "Prospective User" means an exchange, clearing house, financial
institution or other type of entity which provides clearance and settlement
services with respect to, without limitation, futures, securities, options and
other types of financial products.

      (m) "Securities Product" means an equity or debt security or other similar
type of instrument.

      (n) "Securities Products Enhancements" shall have the meaning set forth in
Section 5.4. The modules comprising the Securities Products Enhancements
constitute a portion of the CLEARING 21 Base Product for which a Prospective
User shall be required to obtain a separate sublicense or sublicense upgrade.

      (o)   "Standard CME Share" shall have the meaning set forth in Section
5.2.

      (p)   "Standard NYMEX Share" shall have the meaning set forth in
Section 5.2.

      (q)   "Standard Licensee Share" shall have the meaning set forth in
Section 5.2.

      (r) "Sublicensee" means a Prospective User that has entered into and is a
party to a valid sublicense agreement (or a sublicense upgrade agreement) with
Licensee with respect to the CLEARING 21 Base Product or any part thereof and/or
the Derivative Works, in accordance with the sublicensing authority granted to
Licensee under this Agreement.

      1.2.  REFERENCES.

      Unless something in the subject matter or context is inconsistent with the
resulting interpretation, all references to Sections, Paragraphs, Articles and
Schedules are to Sections, Paragraphs, Articles and Schedules of this Agreement.
The words "hereto", "herein", "of this Agreement", "under this Agreement" and
similar expressions mean and refer to this Agreement.

      1.3.  SCHEDULES.

      The Schedules forming part of this Agreement are as follows:

      Schedule 1  Prospective Users Reserved by CME
      Schedule 2  Prospective Users Reserved by NYMEX
      Schedule 3  Revenue Sharing Tables
      Schedule 4  Exchanges and Clearing Organizations Subject to SBF
                  Marketing Plan
      Schedule 5  CME and NYMEX Invoice Samples

      1.4.  HEADINGS.

                                       4

<Page>

      The inclusion of headings in this Agreement is for convenience of
reference only and does not affect the construction or interpretation of this
Agreement.

      1.5.  NO OBLIGATION.

      No provision of this Agreement shall be construed to bind or obligate
Licensors or Licensee in any way to develop, make further enhancements to or
maintain any current or future version of the CLEARING 21 Base Product or any of
the Derivative Works, including, without limitation, the DEC Enhancements and
the Securities Products Enhancements.

             ARTICLE 2 - GRANT OF LICENSE AND RIGHT TO SUBLICENSE

      2.1.  LICENSE TO PROMOTE, MARKET AND DISTRIBUTE CLEARING 21.

      Subject to the exceptions set forth in Sections 2.4, 3.4 and 3.5 hereof,
Licensors hereby grant to Licensee and Licensee hereby accepts from Licensors,
in accordance with the terms and conditions of this Agreement, an exclusive,
non-transferable, worldwide license to promote and market the CLEARING 21 Base
Product and Derivative Works to Prospective Users and to license and distribute
the CLEARING 21 Base Product and Derivative Works to each such Prospective User,
without the right to further sublicense or distribute the same, solely for use
in connection with the clearing and settlement of contracts, securities and
financial instruments traded or cleared through the facilities of each such
Prospective User; provided, however, that each such Prospective User shall have
first executed a written agreement which complies in all material respects with
the requirements set forth in Section 3.6 hereof. Licensee's duties under this
Agreement may be performed by ATOS-Euronext, a corporation organized and
existing under the laws of France duly registered with the Trade Registry of
Paris under number B 425 100 294 and having its registered offices Palais de la
Bourse, Place de la Bourse 75002 Paris, as a subcontractor. SBF agrees that its
use of ATOS-Euronext as a subcontractor shall not release it from any duties or
responsibilities hereunder and that SBF shall remain responsible to Licensors
for such performance as if it had directly performed hereunder.

      2.2.  LICENSE TO USE CLEARING 21 TRADEMARK.

      Licensors hereby grant to Licensee and Licensee hereby accepts from
Licensors, in accordance with the terms and conditions of this Agreement, a
non-exclusive, non-transferable, worldwide license to use the CLEARING 21
trademark in connection with the performance of this Agreement, together with
the right to license use of such CLEARING 21 trademark to Prospective Users, but
without the right to further sublicense such use. Licensee agrees to acknowledge
Licensors' ownership of the CLEARING 21 trademark in all documents and other
materials employed by Licensee in connection with Licensee's promotion,
marketing and licensing of the CLEARING 21 Base Product and the Derivative Works
pursuant to this Agreement.

                                       5

<Page>

      2.3.  LICENSE TO CREATE DERIVATIVE WORKS.

      Licensors hereby grant to Licensee and Licensee hereby accepts from
Licensors, in accordance with the terms and conditions of this Agreement, a
non-exclusive, non-transferable, worldwide license to create Derivative Works,
together with the right to grant a restricted sublicense to create such
Derivative Works to Prospective Users.

      2.4.  PROSPECTIVE USERS RESERVED BY LICENSORS.

      CME expressly excludes from this Agreement and reserves for itself the
right to promote and market the CLEARING 21 Base Product, any part thereof
and/or the Derivative Works to the Prospective Users listed in Schedule 1
attached hereto. NYMEX expressly excludes from this Agreement and reserves for
itself the right to promote and market the CLEARING 21 Base Product, any part
thereof and/or the Derivative Works to the Prospective Users listed in Schedule
2 attached hereto. Each Licensor reserves for itself the right to license the
Clearing 21 Base Product, any part thereof and/or the Derivative works to
Prospective User in which such Licensor owns at least a 25% equity interest
(excluding however the exchanges listed in Schedule 4.).

      2.5.  OWNERSHIP RIGHTS.

      Licensee acknowledges Licensors' exclusive ownership rights in the
CLEARING 21 trademark and agrees not to assert any ownership interests in such
trademark for itself or on behalf of any Sublicensee. Licensee and its
Sublicensees shall acquire no ownership rights whatsoever in the CLEARING 21
Base Product or the Derivative Works, and any provision to the contrary in any
sublicense agreement entered into by Licensee shall be null and void. Licensee
agrees not to remove Licensors' trademark, copyright or other proprietary
notices embedded in the CLEARING 21 Base Product, and shall require such notices
to be embedded in all Derivative Works created by or for Licensee or a
Sublicensee.

      Derivative Works created by or for Licensee and/or by or for a Sublicensee
shall be the sole property of Licensors. Licensee agrees that all present and
future copyright or patent in any Derivative Work created by or for Licensee is
hereby assigned to Licensors, including, but not limited to, rights to create
derivative works thereon and any renewal rights, and Licensee agrees to execute
any documents necessary to vest full copyright or patent ownership in Licensors,
including waiver of any Licensee moral rights. Licensee agrees to provide
reasonable assistance to Licensors in securing and enforcing such copyrights or
patents; provided, however, that Licensee shall not be required to incur any
additional or extraordinary costs or expenses in connection therewith.

      Licensors shall have a right without restriction to use the Derivative
Works for their own internal business purposes. Except as set forth in Section
2.6 below, Licensors shall also have a right without restriction, but not an
obligation, to incorporate any Derivative Works created by or for Licensee
and/or by or for a Sublicensee into the

                                       6

<Page>

CLEARING 21 Base Product, and to relicense or otherwise redistribute such
incorporated software to other licensees without any accounting therefor to
Licensee or any Sublicensee.

      2.6.  SUBLICENSE PROVISIONS BINDING UPON LICENSORS.

      Licensors agree to be bound by any restrictive provision that is legally
enforceable against Licensee in any sublicense agreement entered into by
Licensee in accordance with this Agreement which prevents Licensee from
relicensing or otherwise redistributing Derivative Works created by or for such
Sublicensee; provided, however, that: (a) Licensee must notify Licensors of the
terms of any such restrictive provision; (b) Licensors may, at their option and
expense, enter into direct negotiations with such Sublicensee with the objective
of removing such restrictive provision; and (c) Licensors shall not be bound by
terms in any sublicense agreement that purport to restrict Licensors from
licensing and/or distributing software similar in function and design to the
subject Derivative Works, provided such software has been developed
independently by or for Licensors without reference to such Derivative Works.

      2.7.  NO OTHER RIGHTS OR INTEREST.

      Except as expressly set forth in this Article 2, this Agreement confers
upon Licensee no proprietary rights to or interest in the CLEARING 21 trademark,
the CLEARING 21 Base Product or the Derivative Works.

                   ARTICLE 3 - RESPONSIBILITIES OF LICENSEE

      3.1.  COSTS AND EXPENSES.

      Licensee shall be solely responsible for any costs and expenses incurred
by Licensee in connection with this Agreement.

      3.2.  EXCLUSIVITY.

      *****, Licensee agrees not to engage in any activity and/or enter into any
agreement with any third party concerning or involving the promotion, marketing,
licensing and/or sublicensing of any product or service which would compete with
the CLEARING 21 Base Product.

      3.3.  REASONABLE COMMERCIAL EFFORTS.

      Subject to the restrictions set forth in Section 2.4 above and Section 3.4
below, Licensee shall employ reasonable commercial efforts to promote, market
and sublicense the CLEARING 21 Base Product and/or the Derivative Works to
Prospective Users, and shall respond to qualified requests for proposal from
such Prospective Users. Licensee shall promote, market and sublicense the
CLEARING 21 Base Product and/or the

                                       7

<Page>

Derivative Works without regard to the business plans, strategic needs or
initiatives of any other person. Every quarter during the term of this
Agreement or any renewal thereof, Licensee shall report to Licensors in
writing the details of all contacts with, requests for information from,
requests for proposals from, proposals and presentations to Prospective
Users, progress of all negotiations and discussions, and business plans for
promoting CLEARING 21.

      Every six months during the term of this Agreement or any renewal
thereof, Licensee shall advise Licensors in writing of the Prospective Users
in which Licensee has expended and/or intends to expend significant amounts
of time, money and effort in connection with the promotion and marketing of
the CLEARING 21 Base Product and/or the Derivative Works. Licensee agrees not
to list on such semi-annual report any Prospective User for which Licensee
has not established, or obtained internal approval to establish, a budget in
connection with the promotion and marketing of the CLEARING 21 Base Product
and/or the Derivative Works. Licensee further agrees to remove from such
semi-annual report any Prospective User for which Licensee's budget for the
promotion and marketing of the CLEARING 21 Base Product and/or the Derivative
Works has been eliminated.

      Failure to comply with the terms stated in this section will constitute a
material breach of this Agreement under Section 8.1 below.

      3.4.  EXCLUDED PROSPECTIVE USERS.

      Licensee agrees not to promote, market or sublicense the CLEARING 21 Base
Product and/or the Derivative Works to any Proposed User that is specifically
identified by name on Schedule 1 hereof. Subject to the conditions set forth in
this Section 3.4, Licensee further agrees to waive the marketing, promotion and
revenue sharing rights to which Licensee is otherwise entitled under this
Agreement with respect to such Prospective Users as are not specifically
identified by name on Schedule 1 or 2 hereof but which may in the future be
selected or designated in good faith by a Licensor as falling within one of the
two general exclusionary categories enumerated in Schedule 1 or 2. If a
licensing agreement entered into by a Licensor pursuant to this Section 3.4
involves a presently unnamed Prospective User referred to in Schedule 1 or 2
that was rightfully included prior to the date of such licensing agreement on
the semi-annual report of Prospective Users most recently prepared for Licensors
by Licensee pursuant to Section 3.3 above, such Licensor shall reimburse
Licensee for reasonable expenses incurred by Licensee that are directly related
to the promotion and marketing to such Prospective User by Licensee of the
CLEARING 21 Base Product and/or the Derivative Works during the one year period
preceding the effective date of such licensing agreement.

      3.5.  LICENSORS' RIGHT TO LICENSE CERTAIN PROSPECTIVE USERS.

      In addition to the reservation of rights in Section 2.4, Licensee agrees
that each Licensor shall have the right to request in writing, at any time
during the term of this Agreement and any extension thereof, that Licensee enter
into a sublicensing agreement

                                       8

<Page>

with a specific Prospective User in connection with the promotion and
marketing of the CLEARING 21 Base Product and/or the Derivative Works. If
Licensee is unable or unwilling to do so within a reasonable time after
receipt of a valid request from Licensor, or if Licensee fails diligently to
pursue reasonable commercial efforts to induce the Prospective User to enter
into a sublicense agreement consistent with the terms of this Agreement,
Licensor shall thereafter be entitled, upon written notice to Licensee, to
pursue a separate licensing agreement, consistent with the terms of this
Agreement, with such Prospective User. If such a licensing agreement is
subsequently entered into by Licensor, Licensee shall be entitled to receive
the applicable payment specified in Section 5.7 hereof. In addition to the
foregoing, if a licensing agreement entered into by Licensor pursuant to this
Section 3.5 involves a Prospective User that was rightfully included prior to
the date of such licensing agreement on the semi-annual report of Prospective
Users most recently prepared for Licensors by Licensee pursuant to Section
3.3 above, Licensor shall reimburse Licensee for reasonable expenses incurred
by Licensee that are directly related to the promotion and marketing to such
Prospective User by Licensee of the CLEARING 21 Base Product and/or the
Derivative Works during the one year period preceding the effective date of
such licensing agreement.

      3.6.  SUBLICENSE AGREEMENT.

      No sublicense agreement entered into by Licensee shall contain terms and
conditions which are inconsistent with this Agreement. Licensee shall prepare
and submit to Licensors the sublicense agreement that Licensee proposes to
employ in connection with the sublicensing of the CLEARING 21 Base Product and
the Derivative Works to each Prospective User.

      Licensee shall obtain Licensors' written approval of such sublicense
agreement prior to entering into an agreement with a Prospective User. Licensee
shall permit Licensors thirty days from the date of receipt of the sublicense
agreement to review such sublicense agreement and to prescribe reasonable
modifications thereto, if any. Licensors shall be deemed to have waived all
rights with respect to the sublicense agreement if Licensors fail to communicate
such modifications to Licensee within such thirty day period. If the sublicense
agreement is identical in all material respects with previously approved
sublicenses, Licensors shall have ten days to approve.

      Licensee agrees to incorporate Licensors' reasonable modifications into
such sublicense agreement. The sublicense shall specify, without limitation,
that the Sublicensee agrees to be bound by the terms, conditions and
restrictions set forth in this Agreement. Licensee agrees to provide Licensors
with a copy of all fully executed sublicense agreements within ten days of the
effective dates thereof.

      3.7.  NEGOTIATION OF SUBLICENSE AGREEMENT.

      Subject to the requirements and restrictions set forth in Section 3.6
above and elsewhere in this Agreement including, without limitation, Articles 5
and 7 hereof, Licensee shall be entitled to negotiate the specific financial and
technical provisions that

                                       9

<Page>

shall govern the sublicense agreement or sublicense upgrade to be offered to
a Prospective User, including, without limitation, the precise sublicense fee
to be requested therefor and the terms and conditions of any software
development agreement governing the creation of Derivative Works for any such
Prospective User, and shall be solely responsible for scheduling any such
technical efforts and fulfilling any other covenants and commitments made by
Licensee therein to such Prospective User.

      3.8.  LICENSORS' PARTICIPATION IN ENHANCEMENTS.

      Licensee shall be obliged to offer Licensors the opportunity to
participate in the development of technical enhancements under monetary terms
equivalent to those negotiated with such Prospective User with respect to the
work to be performed by Licensee's dedicated technical staff and/or long-term
subcontractors; provided, however, that this obligation shall only arise
whenever the amount of work associated with any such technical enhancement
effort exceeds the amount that may be adequately handled by Licensee's dedicated
technical staff and long-term subcontractors used by Licensee to undertake such
technical enhancement effort. Licensors shall have a maximum of fifteen days to
accept or reject an offer by Licensee pursuant hereto.

      3.9.  REPORTING OF DERIVATIVE WORKS.

      Licensee agrees to provide Licensors, on a semi-annual basis commencing
six months after the effective date hereof, with an itemized report containing a
summarized functional description of the Derivative Works developed by or for
Licensee and/or any Sublicensee since the previous semi-annual report which
constitute significant modifications or enhancements to the CLEARING 21 Base
Product. Licensee shall provide an electronic version of the source code and
documentation for each Derivative Work to a Licensor requesting same within
thirty calendar days of such request.

      Licensee agrees to use reasonable efforts to assist Licensors in obtaining
and maintaining patent, trademark, and/or copyright protection in any and all
locations around the world. Licensee agrees to use its best efforts to give
adequate notice to Licensors of enhancements prior to implementation of such
enhancements by each Sublicensee so that patent protection can be obtained

      3. 10.      REPORTING OF FEES.

      Within fifteen days of the end of each calendar quarter beginning with the
first calendar quarter in which a payment is due to Licensors hereunder,
Licensee shall send Licensors a report for such calendar quarter and
cumulatively for the calendar year a detailed account of all fees due to
Licensors under this Agreement including: identification of each Sublicensee by
name and specific site or location; authorized type/model and number of
computers; date of sublicense agreement; specific CLEARING 21 software modules
sublicensed to such Sublicensee; date of installation of each such CLEARING 21
software module; effective dates of maintenance agreements; and the breakdown of
Licensors' and Licensee's respective shares of fees and charges

                                       10

<Page>

accrued and paid (expressed in both the currency of payment and in U.S.
dollars). Upon request, Licensee shall promptly provide Licensors with copies
of all invoices relevant to the calculation of fees due.

      3.11. PAYMENTS TO LICENSORS.

      Any payment due from Licensee to a Licensor under this Agreement, which is
contingent upon a payment schedule entered into between Licensee and a
Sublicensee, shall be payable in accordance with such payment schedule. All such
payments shall be paid to such Licensor at the date of the quarterly report
required by Section 3.10. Licensee agrees to make payments due hereunder to
Licensors in U.S. dollars, at the then-prevailing exchange rate on the date
payment is effected by Licensee. If local law or accounting principles require
that Licensee pay only in response to an invoice, Licensee shall prepare an
invoice per the sample provided by each Licensor in Schedule 5 and forward it to
Licensors for signature and presentation. Licensee shall supply sufficient
detail to explain its calculation of the payments owing to Licensors and will
provide copies of relevant materials upon request. Failure by Licensee to make
payments to Licensors within 45 calendar days of the end of each calendar
quarter shall constitute a material breach of this Agreement under Section 8.1
below.

      3.12. COOPERATION.

      Licensee agrees to cooperate, advise and consult with Licensors as
necessary to reasonably facilitate the successful evolution of the CLEARING 21
Base Product into a global standard for the clearance and settlement of
Securities Products and Derivatives Products, and to avoid wherever possible
unproductive duplication of effort as well as divergence, disparity or conflict
between the CLEARING 21 Base Product and any Derivative Works with respect to
systems design, user interfaces and module functionality.

                  ARTICLE 4 - RESPONSIBILITIES OF LICENSORS

      4.1.  COSTS AND EXPENSES.

      Each licensor shall be solely responsible for its costs and expenses
incurred in connection with this Agreement.

      4.2.  RESTRICTIONS ON DIRECT PROMOTION, MARKETING AND/OR LICENSING.

      Except as set forth in Sections 2.4 and 3.5, Licensors agree not to
promote, market and/or license the CLEARING 21 Base Product and/or the
Derivative Works to any third party during the term of this Agreement or any
extension thereof other than to those Prospective Users listed in Schedule 1 or
2 hereof.

      4.3.  RESTRICTIONS ON COMPETING MARKETING ARRANGEMENTS.

                                       11

<Page>

      Except as expressly permitted elsewhere in this Agreement, Licensors agree
not to enter into any agreement with any third party during the term of this
Agreement or any extension thereof for the purpose of promoting, marketing and
licensing the CLEARING 21 Base Product or the Derivative Works in a manner that
would compete with Licensee.

      4.4.  ENHANCEMENTS.

      Subject to the provisions set forth in Section 1.5 above, Licensors agree
to provide to Licensee, free of additional charge during the initial or any
renewal term of this Agreement, any new versions and any upgrades, modifications
and enhancements to existing versions of the CLEARING 21 Base Product, if any,
which Licensors may develop and offer to all similarly situated licensees of the
CLEARING 21 Base Product, together with any documentation developed by Licensors
therefor and a reasonable amount of training in connection therewith.

      4.5.  LICENSEE'S PARTICIPATION IN ENHANCEMENTS.

      Licensors shall offer Licensee the opportunity to participate in the
development of any such new versions, upgrades, modifications and enhancements
to the CLEARING 21 Base Product undertaken by Licensors, upon monetary terms
satisfactory to both Licensors and Licensee; provided, however, that this
obligation shall only arise whenever the amount of work associated with any such
technical effort exceeds the amount that may be adequately handled by Licensors'
dedicated technical staffs and long-term sub-contractors used by Licensors to
undertake such technical effort. Licensee shall have a maximum of fifteen days
to accept or reject an offer by Licensors pursuant hereto.

      4.6.  MARKETING SPECIALIST.

      During the term of this Agreement or any extension thereof, CME shall make
available to Licensee the services of one CME marketing specialist experienced
in and familiar with the features and functions of the CLEARING 21 Base Product,
when requested to do so by Licensee in connection with the promotion and
marketing of the CLEARING 21 Base Product and/or any Derivative Works to
Prospective Users. CME shall be solely responsible for payroll, travel and other
expenses associated with this marketing specialist.

      4.7.  PAYMENTS TO LICENSEE.

      Any payment due from Licensors to Licensee pursuant to Section 5.7 of this
Agreement which is contingent upon a payment schedule entered into between
Licensors and a Prospective User shall be payable in accordance with such
payment schedule and shall be paid to Licensee within ten days of receipt by
Licensors of a payment from such Prospective User pursuant to such payment
schedule. Licensors agree to make payments due hereunder to Licensee in French
francs, or the successor currency thereto, at the then-prevailing exchange rate
on the date payment is effected by Licensors. Failure by

                                       12

<Page>

Licensors to make payments to Licensee within 45 calendar days of receipt by
Licensors of a payment from a Prospective User pursuant to such payment
schedule shall constitute a material breach of this Agreement under Section
8.1 below.

      4.8.  COOPERATION.

      Licensors agree to cooperate, advise and consult with each other and with
Licensee as necessary to reasonably facilitate the successful evolution of the
CLEARING 21 Base Product into a global standard for the clearance and settlement
of Securities Products and Derivatives Products, and to avoid wherever possible
unproductive duplication of effort as well as divergence, disparity or conflict
between the CLEARING 21 Base Product and any Derivative Works with respect to
systems design, user interfaces and module functionality. Licensors shall
likewise cooperate with each other to share in an equitable manner technical
work for or on behalf of a Prospective User that is offered by Licensee to
Licensors pursuant to Section 3.8 hereof.

                ARTICLE 5 -PRICING, REVENUE SHARING AND TAXES

      5.1.  *****

      5.2.  *****

      5.3.  *****

      5.4.  REVENUE SHARING EXCEPTION NUMBER 2:  SECURITIES PRODUCTS
ENHANCEMENTS.

Subject to the exceptions set forth in Section 5.5 below, the gross price
established by Licensee for each sublicense or sublicense upgrade entered into
between Licensee and a Prospective User which is based upon or derived from a
version of the CLEARING 21 Base Product capable of clearing and settling
Securities Products (the "Securities Products Enhancements") shall be shared by
Licensors and Licensee in the percentages shown in Table C of Schedule 3 until
the absolute aggregate amounts received by Licensee pursuant to this Section 5.4
exceed the Standard Licensee Share for the equivalent number of sublicenses
and/or sublicense upgrades by a total of U.S. *****. Thereafter, future
sublicenses and sublicense upgrades entered into between Licensee and any
Prospective User that would otherwise be subject to this Section 5.4 shall
revert to the standard revenue sharing percentages reflected in Table A of
Schedule 3. However, the percentages reflected in Table C of Schedule 3 shall
only replace the standard revenue sharing percentages reflected in Table A of
Schedule 3 for a given Sublicensee upon commencing the use of CLEARING 21 for
clearing of Securities Products by such Sublicensee.

      5.5.  REVENUE SHARING EXCEPTION NUMBER 3:  DEC ENHANCEMENTS PLUS
SECURITIES PRODUCTS ENHANCEMENTS.

                                       13

<Page>

      In the event that a sublicense or sublicense upgrade is entered into by
Licensee and a Prospective User that includes both the DEC Enhancements and the
Securities Products Enhancements, wherein the overall U.S. ***** cap governing
reversion to the standard revenue sharing percentages reflected in Table A of
Schedule 3 has not been attained by either NYMEX or Licensee pursuant to
Sections 5.3 and 5.4 above, the gross price established by Licensee for each
such sublicense or sublicense upgrade entered into between Licensee and a
Prospective User shall be shared by Licensors and Licensee in the percentages
shown in Table D of Schedule 3 and aggregated in accordance with the provisions
of Sections 5.3 and 5.4 above until: (a) the absolute aggregate amounts received
by NYMEX pursuant to Section 5.3 and this Section 5.5 equal U.S. ***** more than
the Standard NYMEX Share for the equivalent number of relevant sublicenses, or
(b) the absolute aggregate amounts received by Licensee pursuant to Section 5.4
and this Section 5.5 equal U.S. ***** more than the Standard Licensee Share for
the equivalent number of relevant sublicenses. Thereafter, this Section 5.5
shall no longer apply to future sublicenses or sublicense upgrades that involve
both the DEC Enhancements and the Securities Products Enhancements, but rather
the criteria set forth in Sections 5.2, 5.3 and 5.4, whichever is applicable,
shall govern the revenue sharing percentages that apply to any such subsequent
sublicense or sublicense upgrade entered into by Licensee and a Prospective
User.

      5.6.  MAINTENANCE SERVICES.

      Maintenance services related to any sublicense or sublicense upgrade shall
be offered by Licensee to all Sublicensees. Such maintenance services shall
include bug fixes, operating system upgrades and common changes to the CLEARING
21 Base Product. Charges for such maintenance services for each Sublicensee
shall be in accordance with the schedule set out at Section 5.1. Licensee shall
obtain Licensors' prior written approval of any lower or higher rate. Licensee
shall pay ***** percent of such gross annual charges for such maintenance
services to CME and shall keep the remaining ***** percent for itself. The
foregoing annual charge for maintenance services shall not include technical or
help desk support or major enhancements to the CLEARING 21 Base Product
requested by the Sublicensee; Licensee may charge each Sublicensee separately
for such additional services.

      5.7.  PAYMENT TO LICENSEE FOR CERTAIN DIRECT LICENSES.

      Licensors are permitted, pursuant to Section 3.5 hereof, to license the
CLEARING 21 Base Product and/or the Derivative Works directly to a Prospective
User not listed on Schedule 1 or 2 in the event that Licensee is unable or
unwilling to enter into a sublicense agreement with such Prospective User within
a reasonable time following a written request from a Licensor to do so. If
Licensors enter into a license with such a Prospective User, they will pay *****
percent of the gross license fee to Licensee if the license is for Securities
Products only; ***** percent of the gross license fee to Licensee if the license
is for both Securities Products and Derivatives Products; and ***** percent of
the gross license fee to Licensee if the license is for Derivatives Products
only.

                                       14

<Page>

However, the percentages applicable to Securities Products or Securities
Products and Derivatives Products licenses specified herein shall only apply to
a given Sublicensee upon commencing the use of CLEARING 21 for clearing of
Securities Products by such Sublicensee.

      Each Licensor is permitted, pursuant to Section 2.4 hereof, to license the
Clearing 21 Base Product, any part thereof and/or the Derivative works to
certain Prospective Users in which such Licensor owns at least a ***** equity
interest. If Licensor enters into a license with such a Prospective User, it
will pay the greater of ***** of the license fee or ***** to Licensee within 15
days of such Users first use of Clearing 21.

      Notwithstanding any other provision of this Agreement, Licensee is not
entitled to any share of the license fees if Licensors license the CLEARING 21
Base Product and/or the Derivative Works to any Prospective User listed on
Schedule 1 or 2.

      5.8.  RIGHT TO AUDIT RECORDS.

      Licensors and Licensee shall have the right, upon reasonable notice, by
independent audit and at their own respective expense, to audit each other's
records as they affect amounts payable to each other under this Agreement. If
any such audit results in a determination that there has been an under payment
greater than 15% of the payment actually made, then the costs of the audit shall
be borne by the party responsible for the underpayment.

      5.9.  TAXES.

      All amounts payable under this Agreement are exclusive of, and will be
paid without deduction for, all taxes, levies, or similar governmental charges,
however designated, which may be assessed by any jurisdiction based on gross
revenues. Except for corporate income tax imposed on the payee(s) hereunder, or
other taxes, fees or duties relating specifically to this Agreement that may be
imposed by any federal, national, state or municipal taxing authority, the
remitter(s) of any amount due hereunder will pay all taxes including any related
penalties and interest or late charges, levies, or similar governmental charges,
or will provide the payee(s) hereunder with a certificate of exemption
acceptable to the appropriate taxing authority. The payee(s) hereunder agrees to
provide the remitter(s) hereunder with such forms or documents as may be
reasonably requested by such remitter(s) from time to time to certify exemption
from withholding of income tax. The provisions of this Section 5.9 shall survive
any termination of this Agreement.

          ARTICLE 6 - REPRESENTATIONS AND WARRANTIES OF THE PARTIES

      6.1.  REPRESENTATIONS AND WARRANTIES OF CME.

                                       15

<Page>

      CME represents and warrants to Licensee and NYMEX as follows and
acknowledges that Licensee and NYMEX are relying on the following
representations and warranties in connection with the transactions contemplated
hereby:

      (a) CME has the corporate power and the capacity to enter into and to
perform its obligations under this Agreement and this Agreement has been duly
authorized, executed and delivered by CME and is a valid and binding obligation
of CME, enforceable in accordance with its terms;

      (b) CME has obtained all necessary or required approvals to carry out
the terms of this Agreement;

      (c) neither the entering into of this Agreement, nor the performance by
CME of any obligations under this Agreement will contravene, breach or result in
any default under the articles, by-laws, constating documents or other
organizational documents of CME or under any mortgage, lease, agreement, other
legally binding instrument, license, permit, statute, regulation, order,
judgment, decree or law to which CME is a party or by which CME may be bound;
and

      (d) no authorization, consent or approval of, or filing with or notice to
any court or other person or entity that is not also a party to this Agreement
is required in connection with the execution, delivery or performance of this
Agreement by CME.

      6.2.  REPRESENTATIONS AND WARRANTIES OF NYMEX.

      NYMEX represents and warrants to Licensee and CME as follows and
acknowledges that Licensee and CME are relying on the following representations
and warranties in connection with the transactions contemplated hereby:

      (a) NYMEX has the corporate power and the capacity to enter into and to
perform its obligations under this Agreement and this Agreement has been duly
authorized, executed and delivered by NYMEX and is a valid and binding
obligation of NYMEX, enforceable in accordance with its terms;

      (b) NYMEX has obtained all necessary or required approvals to carry out
the terms of this Agreement;

      (c) neither the entering into of this Agreement, nor the performance by
NYMEX of any obligations under this Agreement will contravene, breach or result
in any default under the articles, by-laws, constating documents or other
organizational documents of NYMEX or under any mortgage, lease, agreement, other
legally binding instrument, license, permit, statute, regulation, order,
judgment, decree or law to which NYMEX is a party or by which NYMEX may be
bound; and

                                       16

<Page>

      (d) no authorization, consent or approval of, or filing with or notice to
any court or other person or entity that is not also a party to this Agreement
is required in connection with the execution, delivery or performance of this
Agreement by NYMEX.

      6.3.  REPRESENTATIONS AND WARRANTIES OF LICENSEE.

      Licensee represents and warrants to CME and NYMEX as follows and
acknowledges that CME and NYMEX are relying on the following representations and
warranties in connection with the transactions contemplated hereby:

      (a) Licensee has the corporate power and the capacity to enter into, and
to perform its obligations under this Agreement and this Agreement has been duly
authorized, executed and delivered by Licensee and is a valid and binding
obligation of Licensee, enforceable in accordance with its terms;

      (b) Licensee has obtained all necessary or required approvals to carry
out the terms of this Agreement;

      (c) neither the entering into of this Agreement, nor the performance by
Licensee of any of its obligations under this Agreement will contravene, breach
or result in any default under the articles, by-laws, constating documents or
other organizational documents of Licensee or under any mortgage, lease,
agreement, other legally binding instrument, license, permit, statute,
regulation, order, judgment, decree or law to which Licensee is a party or by
which Licensee may be bound; and

      (d) no authorization, consent or approval of, or filing with or notice to
any court or other person is required in connection with the execution, delivery
or performance of this Agreement by Licensee.

       ARTICLE 7 - WARRANTY, DISCLAIMER AND INDEMNIFICATION PROVISIONS

      7.1.  LICENSORS' WARRANTIES AND WARRANTY DISCLAIMERS.

      Licensors warrant that they own and have the right to license the CLEARING
21 Base Product. Licensors do not warrant uninterrupted operation of the
CLEARING 21 Base Product or that the CLEARING 21 Base Product will meet any
particular requirements of Licensee or any Prospective User. Licensee has
examined the source code for the CLEARING 21 Base Product and agrees to accept
same in "AS-IS" condition. THE WARRANTY GIVEN ABOVE CONSTITUTES THE ONLY
WARRANTY MADE BY LICENSORS WITH RESPECT TO THIS AGREEMENT. LICENSEE HEREBY
WAIVES ALL OTHER WARRANTIES OR GUARANTEES OF LICENSOR, WHETHER EXPRESS OR
IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A
PARTICULAR PURPOSE OR ANY OTHER WARRANTY WITH RESPECT TO THE QUALITY,

                                       17

<Page>

ACCURACY, PERFORMANCE STANDARDS OR FREEDOM FROM ERROR OF THE OPERATION, USE
AND FUNCTION OF THE CLEARING 21 BASE PRODUCT.

      7.2.  LICENSEE'S WARRANTIES.

      Licensee acknowledges and agrees that Licensee will make no
representations to any Prospective User with respect to any warranty purportedly
made by Licensors except for those of ownership or right to license. Licensee
expressly agrees that any performance warranties that Licensee may make to
Sublicensees regarding the CLEARING 21 Base Product and/or the Derivative Works
shall be made only by and in the name of Licensee. Licensee warrants that any
Derivative Works which Licensee may develop hereafter pursuant to this Agreement
shall not infringe the intellectual property rights of any other entity.
Licensee hereby agrees to indemnify Licensors for any loss due to Licensee's
failure to comply with Licensee's obligations hereunder with respect to
warranties.

      7.3.  LICENSORS' DISCLAIMER OF LIABILITY.

      Licensors disclaim liability and shall not be liable to Licensee or any
third party for indirect, special, incidental, exemplary or consequential
damages (including, without limitation, lost profits) related to this Agreement
or resulting from Licensee's or a Sublicensee's use or inability to use the
CLEARING 21 Base Product or the Derivative Works, arising from any cause of
action whatsoever, including contract, warranty, strict liability, or
negligence, even if Licensors have been notified of the possibility of such
damages. Without limiting the generality of the foregoing, Licensors shall not
have any liability to Licensee, any Sublicensee or any other entity based upon a
claim or allegation that, in licensing the CLEARING 21 Base Product and/or the
Derivative Works, Licensors have assumed the responsibility or obligation to
monitor, mitigate or avoid losses sustained by any customer or other participant
in connection with the trading, clearance or settlement of any Derivatives
Product or Securities Product.

      7.4.  LICENSORS' LIMITATION ON RECOVERY.

      Licensors' sole responsibility hereunder shall be limited to refund of any
fees received by Licensors from Licensee or any other person with respect to
this Agreement or any sublicense agreement relating thereto. Under no
circumstances shall the liability of Licensors to Licensee exceed the amounts
due and owing from Licensee to Licensors under this Agreement.

      7.5.  LICENSORS' INDEMNIFICATION OF LICENSEE.

      Licensors agree that they shall indemnify Licensee and its Sublicensees
and save them harmless from any and all costs, losses, damages, liability,
claims and demands (collectively, an "Intellectual Property Claim") incurred by
or made against Licensee and/or such Sublicensees alleging that the CLEARING 21
Base Product infringes

                                       18

<Page>

intellectual property rights of another person. In order to obtain
indemnification under this provision, Licensee must promptly notify Licensors
of any Intellectual Property Claim that is threatened or brought against
Licensee and/or its Sublicensees concerning the CLEARING 21 Base Product.
Licensors shall defend and contest or settle any such Intellectual Property
Claim, at their sole expense, in their own names and/or in the name of
Licensee and/or its Sublicensees, and Licensee must cooperate with and assist
Licensors to the extent that such cooperation may reasonably be required.

      In the event of such infringement, Licensors may, at their sole option and
expense, either: (a) procure from the owner of the intellectual property rights,
the right for Licensee and its Sublicensees to continue the permitted use of the
CLEARING 21 Base Product; or (b) modify the CLEARING 21 Base Product, or the
infringing part or parts thereof, so that it is non-infringing, or replace the
same with a substitute of equal quality approved by Licensee, acting reasonably,
such that the CLEARING 21 Base Product or the substitute shall perform to the
same or better level of performance. Licensors shall have no liability if the
alleged infringement results or arises from or is caused by: (a) the use by
Licensee or a Sublicensee of other than a current release of the CLEARING 21
Base Product as provided by Licensors to Licensee under this Agreement; or (b)
modification of the CLEARING 21 Base Product by or for Licensee or a
Sublicensee; or (c) combination of the CLEARING 21 Base Product by or for
Licensee or a Sublicensee with programs or data not developed by Licensors;
provided the infringement would not have resulted from use of a current release
or absent such modification or combination.

      Notwithstanding any other provision of this Agreement, Licensors provide
no indemnities hereunder regarding the infringement of intellectual property
rights that may be caused by any non-proprietary software incorporated into the
CLEARING 21 Base Product by or for Licensors pursuant to a license granted to
Licensors therefor.

      7. 6. SURVIVAL UPON TERMINATION.

      The provisions of this Article 7 shall survive any termination of this
Agreement.

                        ARTICLE 8 - TERM AND TERMINATION

      8.1.  MATERIAL BREACH.

      Licensors, acting jointly, or Licensee may terminate this Agreement
forthwith in the event of a material breach by their respective counterparty
(including, without limitation, any failure to pay monies due in accordance with
this Agreement) which remains uncured ten calendar days after a demand for
correction of such breach has been given to the breaching party.

      8.2.  TERM; RENEWAL.

                                       19

<Page>

      *****. This Agreement shall be renewed automatically for successive terms
of three years; provided, however, that Licensee may notify Licensors or
Licensors, acting jointly, may notify Licensee of their respective intentions to
terminate participation in the Agreement at the end of the initial term or any
successive term not later than twelve months prior to the expiration of the
initial term or any successive term. This Agreement shall not fail to be renewed
automatically by virtue of a decision by a Licensor to terminate its
participation in the Agreement unless the other Licensor decides at the same
time to terminate its participation in the Agreement.

      8.3.  SUPERSEDENCE OF PRIOR AGREEMENT.

      The terms of this Agreement supersede the conflicting provisions, if any,
in an agreement entered into by and between the Licensors effective September 1,
1993 (the "Bilateral Agreement"). Should one Licensor under this Agreement cease
to participate in this Agreement for any reason, while the other Licensor
remains a party hereto, Licensors shall be obligated thereupon to initiate good
faith discussions with each other to determine how to resolve any conflicting
obligations between the provisions of the Bilateral Agreement and those of this
Agreement. If Licensors are unable to reach a consensus with respect to the
subject matter hereof within ninety days thereafter, the Bilateral Agreement
shall thereupon be deemed terminated, each Licensor shall be free to act
independently of the other Licensor in connection with the promotion and
marketing of the CLEARING 21 Base Product, and the Derivative Works that have
not yet been incorporated into the CLEARING 21 Base Product on the date of the
termination of the Bilateral Agreement shall be deemed to be owned solely by the
Licensor which remains a party to this Agreement. Nothing contained in this
Section 8.3 shall be construed to affect any of Licensee's rights under this
Agreement.

      8.4.  RIGHTS OF ACTION.

      Neither the termination of this Agreement nor the cessation of
participation in this Agreement by either Licensor shall affect any right of
action of any party arising from anything which was done or not done, as the
case may be, prior to such termination taking effect.

      8.5.  CONTINUATION OF SUBLICENSE AGREEMENTS.

      Neither the termination of this Agreement for any reason, nor the
cessation of participation in this Agreement by either Licensor, shall terminate
any sublicense agreement which is validly in effect on the date of such
termination or the date of cessation of such participation, and each such
sublicense agreement shall remain in full force and effect thereafter in
accordance with its terms. No termination of this Agreement shall affect the
ability of Licensee to fulfill its obligations under any commitment made by
Licensee in good faith and in accordance with this Agreement prior to the
effective date of such termination including, but not limited to, retention of
source code for the CLEARING 21 Base Product and Derivative Works solely for the
purpose of providing ongoing maintenance to existing Sublicensees. Termination
of this Agreement for any

                                       20

<Page>

reason shall not relieve Licensee of the obligation to pay any amounts due
Licensors with respect to pre-termination commitments from Sublicensees, even
though such amounts may be paid to Licensee after termination. The provisions
of this Section 8.5 shall survive any termination of this Agreement.

                               ARTICLE 9 - GENERAL

      9.1.  CONFIDENTIAL INFORMATION.

      Licensee acknowledges that the CLEARING 21 Base Product and the Derivative
Works contain proprietary and confidential information of Licensors. Licensee
agrees to safeguard such confidential information by employing the highest
degree of care and diligence that it takes to safeguard its own most
confidential information, and such care shall not be any less than would be
taken by a reasonable company to safeguard such information. Licensee shall
require its Sublicensees to exercise an equal degree of care with respect to
such confidential information.

      The provisions of this Agreement relating to the proprietary and
confidential nature of the CLEARING 21 Base Product and the Derivative Works
shall survive any termination of this Agreement.

      9.2.  FORCE MAJEURE.

      Neither Licensors nor Licensee shall be liable for delay or failure in
performance, except the payment of money, resulting from acts beyond the control
of such party, including, but not limited to Acts of God, acts of war, fire,
flood, or other disaster, act of government, strike, lockout, communication line
or power failures.

      9.3.  GOVERNING LAW, ARBITRATION, AND CHOICE OF JURISDICTION.

      All actions arising from disputes initiated by either Licensor against
Licensee in connection with this Agreement shall be heard and finally settled
under the Rules of Conciliation and Arbitration of the International Chamber of
Commerce by one or more arbitrators appointed in accordance with said Rules.
Resolution of all such disputes shall be governed in all respects by the
substantive laws of the Republic of France. The arbitration proceeding related
thereto shall be conducted in English. The place of arbitration in such cases
shall be Zurich, Switzerland.

      All actions arising from disputes initiated by Licensee against either or
both Licensors or by one Licensor against the other Licensor in connection with
this Agreement shall be heard and finally settled in the federal or state courts
located in the City of New York, State of New York. Resolution of all such
disputes shall be governed in all respects by the substantive laws of the State
of New York without recourse to choice of law principles.

                                       21

<Page>

      9.4.  ASSIGNMENT OR DELEGATION.

      Except as provided in Section 2.1 above, no party hereto may assign its
rights or delegate its obligations hereunder to any other person or entity
without the prior written consent of the other parties hereto; provided,
however, that NYMEX may assign or otherwise transfer this Agreement to New York
Mercantile Exchange Inc., a Delaware for-profit company, without the consent of
SBF or CME.

      9.5.  NOTICES.

      Any notice or communication to be given under this Agreement may be
effectively given by delivering the same at the addresses hereinafter set out or
by sending the same by prepaid registered mail or facsimile to the parties at
such addresses. Any notice so mailed shall be deemed to have been received on
the fifth day next following the mailing thereof provided the postal service is
in operation during such time and any notice sent by facsimile shall be deemed
to have been received on transmission. The mailing addresses and facsimile
numbers of the parties for the purposes of this Agreement shall respectively be:

IN THE CASE OF EURONEXT-PARIS :

      EURONEXT-PARIS
      39, rue Cambon
      75039 PARIS, FRANCE
      Attention : Jean-Francois Theodore, Chairman and Chief Executive
      Officer
      Facsimile:  (33 1) 49.27.16.12

      WITH A COPY TO:

      EURONEXT-PARIS
      39, rue Cambon
      75039 PARIS, FRANCE
      Attention : Patrick Stephan, Special Advisor to the Chairman
      Facsimile:  (33 1) 49.27.14.33

IN THE CASE OF CME:

      CHICAGO MERCANTILE EXCHANGE INC.
      30 South Wacker Drive
      CHICAGO, ILLINOIS 60606 U.S.A.
      Attention:  James J. McNulty, President and Chief Executive Officer
      Facsimile:  (312) 648-3625

      WITH A COPY TO:

                                       22

<Page>

      CHICAGO MERCANTILE EXCHANGE INC.
      30 South Wacker Drive
      CHICAGO, ILLINOIS 60606 U.S.A.
      Attention:  Craig S. Donohue, Managing Director,
                  Business Development and Corporate/Legal Affairs
      Facsimile:  (312) 930-3323

IN THE CASE OF NYMEX:

      NEW YORK MERCANTILE EXCHANGE INC.
      One North End Avenue
      World Financial Center
      NEW YORK, NEW YORK 10282-1101 U.S.A.
      Attention:  Neal Wolkoff, Executive Vice President
      Facsimile:  (212) 301-4625

      WITH A COPY TO:

      NEW YORK MERCANTILE EXCHANGE INC.
      One North End Avenue
      World Financial Center
      NEW YORK, NEW YORK 10282-1101 U.S.A.
      Attention:  Christopher K. Bowen, Senior Vice President and General
                  Counsel
      Facsimile:  (212) 299-2299

      Any party may from time to time notify the others, in accordance with the
provisions of this Agreement, of any change of address or facsimile number which
thereafter, until changed by like notice, shall be the address or facsimile
number of such party for all purposes of this Agreement.

      9.6.  COMPLETE AGREEMENT.

      Except as set forth below, this Agreement, including the Schedules
attached hereto, contains the complete and exclusive statement of the Agreement
between the Licensors and Licensee with respect to the subject matter hereof and
supersedes all prior and contemporaneous agreements, understandings, proposals,
negotiations, representations or warranties of any kind, whether oral or
written.

      9.7.  SEVERABILITY.

      If any provision of this Agreement is declared by a court of competent
jurisdiction to be invalid, illegal or unenforceable, the parties agree that
such invalidity, illegality or unenforceability shall not affect the validity of
the remaining provisions of this Agreement and further agree to substitute for
the invalid provision a valid provision

                                       23

<Page>

which approximates the intent and economic effect of the invalid provision as
closely as possible.

      9.8.  AMENDMENT.

      No provision of this Agreement may be amended, altered or waived except by
a further written agreement among the parties.

      9.9.  NO WAIVERS.

      No failure on the part of any party to insist upon strict adherence to any
term or provision of this Agreement on any occasion shall be considered a waiver
of that term or provision and shall not deprive any such party of the right to
subsequently insist upon strict adherence to that term or provision or any other
term or provision of this Agreement.

      9.10. CONSENTS, APPROVALS AND REQUESTS.

      All consents and approvals to be given by any party under this Agreement
shall not be unreasonably withheld or delayed.

      9.11. REMEDIES.

      Licensors and Licensee acknowledge and agree that any violation of their
respective obligations under this Agreement will cause irreparable injury to
their counterparty herein, that each party's remedy at law for any violations or
threatened violations thereof may be inadequate and that each party shall not be
required to prove the inadequacy of legal remedies in order to become entitled
to a temporary or permanent injunction or other equitable relief specifically to
enforce such obligations. Licensors and Licensee consent to the issuance of
temporary and permanent injunctions to enforce such obligations. Notwithstanding
the foregoing, each party's rights and remedies under this Agreement are
cumulative and in addition to, and not in lieu of, any other rights and remedies
allowed at law or in equity.

      9.12. CONTRACTUAL STATUTE OF LIMITATIONS.

      No action or claim relating to this Agreement may be instituted more than
one year after the date upon which the aggrieved party becomes aware of the
event giving rise to such action or claim.

      9.13. SPAN-REGISTERED TRADEMARK-.

      With respect to the CLEARING 21 Base Product and/or the Derivative Works,
a Prospective User that intends to adopt the SPAN-Registered Trademark-
performance bond and risk management system must acquire a license for SPAN from
CME, *****. A Prospective

                                       24

<Page>

User so electing to use SPAN must execute CME's standard SPAN license
agreement and agree to comply with its terms.

      This Agreement shall not be construed as restricting in any way CME's
right to license the SPAN system to any other entity outside of this Agreement,
nor shall the existence of the Agreement in and of itself be construed as
granting the other parties to this Agreement any rights whatsoever with respect
to the SPAN system.

      IN WITNESS WHEREOF, Licensors and Licensee have executed this Agreement
effective on the date first above written.

EURONEXT-PARIS

/s/ Jean-Francois Theodore
--------------------------------------
By Mr. Jean-Francois Theodore
Chairman and Chief Executive Officer

CHICAGO MERCANTILE EXCHANGE INC.

/s/ Mr. James J. McNulty
--------------------------------------
By Mr. James J. McNulty
President and Chief Executive Officer

NEW YORK MERCANTILE EXCHANGE  INC.

/s/ Mr. Neal Wolkoff
--------------------------------------
By Mr. Neal Wolkoff
Executive Vice President

                                       25

<Page>

                                   SCHEDULE 1
         TO CLEARING 21 SOFTWARE MARKETING AND DISTRIBUTION AGREEMENT

                        PROSPECTIVE USERS RESERVED BY CME

                                    *****

                                      S1-1

<Page>

                                   SCHEDULE 2
         TO CLEARING 21 SOFTWARE MARKETING AND DISTRIBUTION AGREEMENT

                       PROSPECTIVE USERS RESERVED BY NYMEX

                                    *****

                                      S2-1
<Page>

                                   SCHEDULE 3
         TO CLEARING 21 SOFTWARE MARKETING AND DISTRIBUTION AGREEMENT

                             REVENUE SHARING TABLES

                                    TABLE A:

REVENUE SHARING PERCENTAGES GOVERNED EXCLUSIVELY BY SECTION 5.2 OF THE CLEARING
21 SOFTWARE MARKETING AND DISTRIBUTION AGREEMENT

<Table>
<Caption>
-------------------------------------------------------------------
    SUBLICENSE GRANTED IN:         CME        NYMEX     LICENSEE
-------------------------------------------------------------------
<S>                              <C>         <C>        <C>
   Standard CLEARING 21 Base     *****       *****       *****
   Product
-------------------------------------------------------------------
</Table>

                                    TABLE B:

REVENUE SHARING PERCENTAGES GOVERNED BY SECTION 5.3 BUT NOT SECTION 5.5 OF THE
CLEARING 21 SOFTWARE MARKETING AND DISTRIBUTION AGREEMENT

<Table>
<Caption>
-------------------------------------------------------------------
    SUBLICENSE GRANTED IN:          CME        NYMEX      LICENSEE
-------------------------------------------------------------------
                                <C>         <C>        <C>
   DEC Enhancements, subject to    *****       *****       *****
   overall U.S. ***** cap on
   NYMEX's excess revenues
-------------------------------------------------------------------
</Table>

                                      S3-1

<Page>

                                    TABLE C:

REVENUE SHARING PERCENTAGES GOVERNED BY SECTION 5.4 BUT NOT SECTION 5.5 OF THE
CLEARING 21 SOFTWARE MARKETING AND DISTRIBUTION AGREEMENT

<Table>
<Caption>

-------------------------------------------------------------------
    SUBLICENSE GRANTED IN:         CME        NYMEX     LICENSEE
-------------------------------------------------------------------
<S>                              <C>          <C>       <C>
    Standard CLEARING 21 Base    *****        *****     *****
    Product plus Securities
    Products Enhancements,
    subject to overall U.S.
    ***** cap on Licensee's
    excess revenues
-------------------------------------------------------------------
    Securities Products          *****       *****       *****
    Enhancements only, subject
    to overall U.S. ***** cap
    on Licensee's excess
    revenues
-------------------------------------------------------------------
</Table>

                                    TABLE D:

REVENUE SHARING PERCENTAGES GOVERNED BY SECTION 5.5 OF THE CLEARING 21 SOFTWARE
MARKETING AND DISTRIBUTION AGREEMENT

<Table>
<Caption>
-------------------------------------------------------------------
    SUBLICENSE GRANTED IN:         CME        NYMEX     LICENSEE
-------------------------------------------------------------------
<S>                              <C>         <C>         <C>
   DEC Enhancements plus         *****       *****       *****
   both standard CLEARING 21
   Base Product and
   Securities Products
   Enhancements, subject to
   overall U.S. ***** cap on
   both NYMEX's and
   Licensee's excess revenues
-------------------------------------------------------------------
    DEC Enhancements plus         *****       *****       *****
   only Securities Products
   Enhancements, subject to
   overall U.S. ***** cap on
   both NYMEX's and
   Licensee's excess revenues
-------------------------------------------------------------------
</Table>

                                      S3-2

<Page>

                                   SCHEDULE 4
         TO CLEARING 21 SOFTWARE MARKETING AND DISTRIBUTION AGREEMENT

      EXCHANGES AND CLEARING ORGANIZATIONS SUBJECT TO SBF MARKETING PLAN

                                    *****

                                      S4-1

<Page>

                                   SCHEDULE 5
         TO CLEARING 21 SOFTWARE MARKETING AND DISTRIBUTION AGREEMENT

                          CME AND NYMEX INVOICE SAMPLES

                                      S5-1

<Page>

                           CHICAGO MERCANTILE EXCHANGE
                              30 SOUTH WACKER DRIVE
                                CHICAGO, IL 60606

INVOICE

TO:   ATOS-Euronext                             INVOICE NO.
     [EXAMPLE: C21-Q1-2000]
      39, rue Cambon
      75001 Paris                         DATE:
      France

     C21 Royalties due to CME for licensing of C21 to [EXCHANGE 1] ________
     Euros

      C21 Royalties due to CME for licensing of C21 to [EXCHANGE 2] ________
      Euros

      Total Amount Due                                ________    Euros

      Please submit payment via wire.

      Wiring Instructions:
            Bank 1
            CME General Account
            Account #50-29805
            ABA Routing Number is 071000013

<Page>

                          NEW YORK MERCANTILE EXCHANGE

                                     INVOICE

TO:   ATOS-Euronext                             INVOICE NO.
      [EXAMPLE: C21-Q1-2000]
      39, rue Cambon
      75001 Paris                         DATE:
      France

      C21 Royalties due to NYMEX for licensing of C21 to [EXCHANGE 1]
      ________    Euros

      C21 Royalties due to NYMEX for licensing of C21 to [EXCHANGE 2]
      ________    Euros

      Total Amount Due                                ________    Euros

      Please submit payment via wire.

      Wiring Instructions:<Page>

                                                                EXHIBIT 10.16
---------------------------------------------------------------------

                  CHICAGO MERCANTILE EXCHANGE HOLDINGS INC.

                                       and

                          MELLON INVESTOR SERVICES LLC

                                  Rights Agent

                                Rights Agreement

<Page>

                                                 TABLE OF CONTENTS
<Table>
<Caption>
                                                                                                 PAGE
                                                                                                 ----
<S>                                                                                              <C>
SECTION 1.        CERTAIN DEFINITIONS...............................................................1
SECTION 2.        APPOINTMENT OF RIGHTS AGENT.......................................................5
SECTION 3.        ISSUE OF RIGHTS CERTIFICATES......................................................5
SECTION 4.        FORM OF RIGHTS CERTIFICATES.......................................................7
SECTION 5.        COUNTERSIGNATURE AND REGISTRATION.................................................9
SECTION 6.        TRANSFER, SPLIT UP, COMBINATION AND EXCHANGE OF RIGHTS CERTIFICATES;
                  MUTILATED, DESTROYED, LOST OR STOLEN RIGHTS CERTIFICATES..........................9
SECTION 7.        EXERCISE OF RIGHTS; PURCHASE PRICE; EXPIRATION DATE OF RIGHTS....................10
SECTION 8.        CANCELLATION AND DESTRUCTION OF RIGHTS CERTIFICATES..............................12
SECTION 9.        RESERVATION AND AVAILABILITY OF CAPITAL STOCK....................................13
SECTION 10.       PREFERRED STOCK RECORD DATE......................................................15
SECTION 11.       ADJUSTMENT OF PURCHASE PRICE, NUMBER AND KIND OF SHARES OR NUMBER OF RIGHTS......15
SECTION 12.       CERTIFICATE OF ADJUSTED PURCHASE PRICE OR NUMBER OF SHARES.......................25
SECTION 13.       CONSOLIDATION, MERGER OR SALE OR TRANSFER OF ASSETS OR
                  EARNING POWER....................................................................25
SECTION 14.       FRACTIONAL RIGHTS AND FRACTIONAL SHARES..........................................28
SECTION 15.       RIGHTS OF ACTION.................................................................29
SECTION 16.       AGREEMENT OF RIGHTS HOLDERS......................................................30
SECTION 17.       RIGHTS CERTIFICATE HOLDER NOT DEEMED A SHAREHOLDER...............................30
SECTION 18.       CONCERNING THE RIGHTS AGENT......................................................31
SECTION 19.       MERGER OR CONSOLIDATION OR CHANGE OF NAME OF RIGHTS AGENT........................31
SECTION 20.       DUTIES OF RIGHTS AGENT...........................................................32
SECTION 21.       CHANGE OF RIGHTS AGENT...........................................................34
SECTION 22.       ISSUANCE OF NEW RIGHTS CERTIFICATES..............................................35
SECTION 23.       REDEMPTION AND TERMINATION.......................................................36
SECTION 24.       EXCHANGE.........................................................................37
SECTION 25.       NOTICE OF CERTAIN EVENTS.........................................................38
SECTION 26.       NOTICES..........................................................................39
SECTION 27.       SUPPLEMENTS AND AMENDMENTS.......................................................40
SECTION 28.       SUCCESSORS.......................................................................41
SECTION 29.       DETERMINATIONS AND ACTIONS BY THE BOARD OF DIRECTORS, ETC........................41
SECTION 30.       BENEFITS OF THIS AGREEMENT.......................................................41
SECTION 31.       SEVERABILITY.....................................................................41
SECTION 32.       GOVERNING LAW....................................................................42
SECTION 33.       COUNTERPARTS.....................................................................42
SECTION 34.       DESCRIPTIVE HEADINGS.............................................................42
Exhibit A - Certificate of Designation, Preferences and Rights
Exhibit B - Form of Rights Certificate
Exhibit C - Form of Summary of Rights
</Table>

                                       i
<Page>

                                RIGHTS AGREEMENT

            RIGHTS AGREEMENT, dated as of ___________, 2001 (the "Agreement"),
between Chicago Mercantile Exchange Holdings Inc., a Delaware corporation (the
"Company"), and Mellon Investor Services LLC, a national banking association
(the "Rights Agent").

                             W I T N E S S E T H

            WHEREAS, on August 2, 2001, the Board of Directors of the Company
authorized this Agreement which provides for the issuance by the Company of
Rights, initially representing the right to purchase one one-thousandth of a
share of Series A Junior Participating Preferred Stock (the "Preferred
Stock") of the Company having the rights, powers and preferences set forth in
the form of the Certificate of Designation attached hereto as Exhibit A, upon
the terms and subject to the conditions hereinafter set forth (the "Rights"),
and has further authorized the issuance of one Right, (as such number may
hereinafter be adjusted pursuant to the provisions of Section 11(p) hereof)
for each share of Class A Common Stock, Class B-1 Common Stock, Class B-2
Common Stock, Class B-3 Common Stock and Class B-4 Common Stock
(collectively, the "Common Stock"), respectively, issued from and after the
Effective Date (the "Effective Date") of the Merger (as defined below)
(including shares of Common Stock issued pursuant to the Merger) (whether
originally issued or delivered from the Company's treasury) and the
Distribution Date and in certain circumstances provided in Section 22 hereof,
after the Distribution Date;

            NOW, THEREFORE, in consideration of the premises and the mutual
agreements herein set forth, the parties hereby agree as follows:

            Section 1. CERTAIN DEFINITIONS. For purposes of this Agreement,
the following terms have the meanings indicated:

                  (a) "Acquiring Person" shall mean any Person who or which,
together with all Affiliates and Associates of such Person, shall at any time
from and after the Effective Date be the Beneficial Owner of (A) 15% or more
of the shares of Common Stock then outstanding or (B) 15% or more of the
shares of Class A Common Stock then outstanding, but shall not include (i)
the Company, (ii) any Subsidiary of the Company, (iii) Chicago Mercantile
Exchange Inc. ("CME"), (iv) any employee benefit plan of the Company or of
any Subsidiary of the Company, (v) any Person or entity organized, appointed
or established by the Company for or pursuant to the terms of any such plan,
(vi) any Person who becomes the Beneficial Owner of 15% or more of the shares
of either Common Stock or Class A Common Stock then outstanding as a result
of a reduction in the number of shares of Common

                                       1
<Page>

Stock outstanding due to the repurchase of shares of Common Stock by the
Company, unless and until such Person, after becoming aware that such Person
has become the Beneficial Owner of 15% or more of the then outstanding shares
of Common Stock or Class A Common Stock, acquires beneficial ownership of
additional shares of Common Stock representing one percent (1%) or more of
the shares of Common Stock then outstanding, or (vii) any such Person who has
reported or is required to report such ownership (but less than 25%) on
Schedule 13G under the Exchange Act (or any comparable or successor report)
or on Schedule 13D under the Exchange Act (or any comparable or successor
report) which Schedule 13D does not state any intention to or reserve the
right to control or influence the management or policies of the Company or
engage in any of the actions specified in Item 4 of such Schedule (other than
the disposition of the Common Stock) and, within 10 Business Days of being
requested by the Company to advise it regarding the same, certifies to the
Company that such Person acquired shares of Common Stock in excess of 14.9%
inadvertently or without knowledge of the terms of the Rights and who,
together with all Affiliates and Associates, thereafter does not acquire
additional shares of Common Stock while the Beneficial Owner of 15% or more
of the shares of Common Stock then outstanding; provided, however, that if
the Person requested to so certify fails to do so within 10 Business Days,
then such Person shall become an Acquiring Person immediately after such 10
Business Day Period.

                  (b) "Affiliate" and "Associate" shall have the respective
meanings ascribed to such terms in Rule 12b-2 of the General Rules and
Regulations under the Securities Exchange Act of 1934, as amended and in
effect on the date of this Agreement (the "Exchange Act").

                  (c) A Person shall be deemed the "Beneficial Owner" of, and
shall be deemed to "beneficially own," any securities:

                        (i) which such Person or any of such Person's Affiliates
      or Associates, directly or indirectly, has the right to acquire (whether
      such right is exercisable immediately or only after the passage of time)
      pursuant to any agreement, arrangement or understanding (whether or not in
      writing) or upon the exercise of conversion rights, exchange rights,
      rights, warrants or options, or otherwise; PROVIDED, however, that a
      Person shall not be deemed the "Beneficial Owner" of, or to "beneficially
      own," (A) securities tendered pursuant to a tender or exchange offer made
      by such Person or any of such Person's Affiliates or Associates until such
      tendered securities are accepted for purchase or exchange, or (B)
      securities issuable upon exercise of Rights at any time prior to the
      occurrence of a Triggering Event, or (C) securities issuable upon exercise
      of Rights

                                       2
<Page>

      from and after the occurrence of a Triggering Event which Rights were
      acquired by such Person or any of such Person's Affiliates or Associates
      prior to the Distribution Date or pursuant to Section 3(a) or Section 22
      hereof (the "Original Rights") or pursuant to Section 11(i) hereof in
      connection with an adjustment made with respect to any Original Rights;

                        (ii) which such Person or any of such Person's
      Affiliates or Associates, directly or indirectly, has the right to vote or
      dispose of or has "beneficial ownership" of (as determined pursuant to
      Rule 13d-3 of the General Rules and Regulations under the Exchange Act),
      including pursuant to any agreement, arrangement or understanding, whether
      or not in writing; PROVIDED, however, that a Person shall not be deemed
      the "Beneficial Owner" of, or to "beneficially own," any security under
      this subparagraph (ii) as a result of an agreement, arrangement or
      understanding to vote such security if such agreement, arrangement or
      understanding: (A) arises solely from a revocable proxy given in response
      to a public proxy or consent solicitation made pursuant to, and in
      accordance with, the applicable provisions of the General Rules and
      Regulations under the Exchange Act, and (B) is not also then reportable by
      such Person on Schedule 13D under the Exchange Act (or any comparable or
      successor report); or

                        (iii) which are beneficially owned, directly or
      indirectly, by any other Person (or any Affiliate or Associate thereof)
      with which such Person (or any of such Person's Affiliates or Associates)
      has any agreement, arrangement or understanding (whether or not in
      writing), for the purpose of acquiring, holding, voting (except pursuant
      to a revocable proxy as described in the proviso to subparagraph (ii) of
      this paragraph (c)) or disposing of any voting securities of the Company;
      PROVIDED, however, that nothing in this paragraph (c) shall cause a person
      engaged in business as an underwriter of securities to be the "Beneficial
      Owner" of, or to "beneficially own," any securities acquired through such
      person's participation in good faith in a firm commitment underwriting
      until the expiration of forty days after the date of such acquisition.

                  (d) "Business Day" shall mean any day other than a Saturday,
Sunday or a day on which banking institutions in the State of Illinois are
authorized or obligated by law or executive order to close.

                                       3
<Page>

                  (e) "Class A Common Stock" shall mean the Class A Common
Stock, par value $.01 per share, of the Company.

                  (f) "Class B Common Stock" shall mean the Class B Common
Stock, par value $.01 per share, of the Company.

                  (g) "Class B-1 Common Stock" shall mean the Class B Common
Stock designated as Class B-1.

                  (h) "Class B-2 Common Stock" shall mean the Class B Common
Stock designated as Class B-2.

                  (i) "Class B-3 Common Stock" shall mean the Class B Common
Stock designated as Class B-3.

                  (j) "Class B-4 Common Stock" shall mean the Class B Common
Stock designated as Class B-4.

                  (k) "Close of Business" on any given date shall mean 5:00
P.M., Chicago, Illinois time, on such date; PROVIDED, however, that if such
date is not a Business Day it shall mean 5:00 P.M., Chicago, Illinois time,
on the next succeeding Business Day.

                  (l) "Common Stock" shall mean shall mean the Class A Common
Stock and the Class B Common Stock of the Company, except that "Common Stock"
when used with reference to any Person other than the Company shall mean the
capital stock of such Person with the greatest voting power, or the equity
securities or other equity interest having power to control or direct the
management, of such Person.

                  (m) "Merger" shall mean the transactions contemplated by
the merger agreement among the Company, CME and CME Merger Subsidiary Inc.,
whereby CME Merger Subsidiary Inc. will be merged with and into CME, CME will
become a wholly owned subsidiary of the Company and the former shareholders
of CME will become the shareholders of the Company.

                  (n) "Person" shall mean any individual, firm, corporation,
partnership or other entity.

                  (o) "Preferred Stock" shall mean shares of Series A Junior
Participating Preferred Stock, par value $.01 per share, of the Company, and,
to the extent that there are not a sufficient number of shares of Series A
Junior Participating Preferred Stock authorized to permit the full exercise
of the Rights, any other series

                                       4
<Page>

of Preferred Stock, par value $.01 per share, of the Company designated for
such purpose containing terms substantially similar to the terms of the
Series A Junior Participating Preferred Stock.

                  (p) "Section 11(a)(ii) Event" shall mean any event
described in Section 11(a)(ii) hereof.

                  (q) "Section 13 Event" shall mean any event described in
clauses (x), (y) or (z) of Section 13(a) hereof.

                  (r) "Stock Acquisition Date" shall mean the first date of
public announcement (which, for purposes of this definition, shall include,
without limitation, a report filed pursuant to Section 13(d) under the
Exchange Act) by the Company or an Acquiring Person that an Acquiring Person
has become such.

                  (s) "Subsidiary" shall mean, with reference to any Person,
any corporation of which an amount of voting securities sufficient to elect
at least a majority of the directors of such corporation is beneficially
owned, directly or indirectly, by such Person, or otherwise controlled by
such Person.

                  (t) "Triggering Event" shall mean any Section 11(a)(ii)
Event or any Section 13 Event.

            Section 2. APPOINTMENT OF RIGHTS AGENT. The Company hereby
appoints the Rights Agent to act as agent for the Company and the holders of
the Rights (who, in accordance with Section 3 hereof, shall prior to the
Distribution Date also be the holders of the Common Stock) in accordance with
the terms and conditions hereof, and the Rights Agent hereby accepts such
appointment. The Company may from time to time appoint such Co-Rights Agents
as it may deem necessary or desirable.

            SECTION 3. ISSUE OF RIGHTS CERTIFICATES.

                  (a) Until the earlier of (i) the Close of Business on the
tenth day after the Stock Acquisition Date (or, if the tenth day after the
Stock Acquisition Date occurs before the Effective Date, the Close of
Business on the Effective Date), or (ii) the Close of Business on the tenth
Business Day (or such later date as the Board shall determine) after the date
that a tender or exchange offer by any Person (other than the Company, any
Subsidiary of the Company, any employee benefit plan of the Company or of any
Subsidiary of the Company, or any Person or entity organized, appointed or
established by the Company for or pursuant to the terms of any such plan) is
first published or sent or given within the meaning of Rule 14d-2(a) of the
General Rules and Regulations under the Exchange Act, if upon consummation

                                       5
<Page>

thereof, such Person would become an Acquiring Person (the earlier of (i) and
(ii) being herein referred to as the "Distribution Date"), (x) the Rights
will be evidenced (subject to the provisions of paragraph (b) of this Section
3) by the certificates for the Class A Common Stock, the Class B-1 Common
Stock, the Class B-2 Common Stock, the Class B-3 Common Stock and the Class
B-4 Common Stock, registered in the names of the holders of such class of
Common Stock (which certificates for the Class A Common Stock, the Class B-1
Common Stock, the Class B-2 Common Stock, the Class B-3 Common Stock and the
Class B-4 Common Stock, shall be deemed also to be certificates for Rights)
and not by separate certificates, and (y) the Rights will be transferable
only in connection with the transfer of the underlying shares of Common Stock
(including a transfer to the Company). As soon as practicable after the
Distribution Date, the Rights Agent will send by first-class, insured,
postage prepaid mail, to each record holder of the Class A Common Stock, the
Class B-1 Common Stock, the Class B-2 Common Stock, the Class B-3 Common
Stock and the Class B-4 Common Stock, respectively, as of the Close of
Business on the Distribution Date, at the address of such holder shown on the
records of the Company, one or more Rights Certificates, in substantially the
form of Exhibit B evidencing one Right for each share of Class A Common
Stock, one Right for each share of Class B-1 Common Stock, one Right for each
share of Class B-2 Common Stock, one Right for each share of Class B-3 Common
Stock, and one Right for each share of Class B-4 Common Stock (the "Rights
Certificates"), so held, subject to adjustment as provided herein. In the
event that an adjustment in the number of Rights per share of Common Stock
has been made pursuant to Section 11(p) hereof, at the time of distribution
of the Rights Certificates, the Company shall make the necessary and
appropriate rounding adjustments (in accordance with Section 14(a) hereof) so
that Rights Certificates representing only whole numbers of Rights are
distributed and cash is paid in lieu of any fractional Rights. As of and
after the Distribution Date, the Rights will be evidenced solely by such
Rights Certificates.

                  (b) With respect to certificates for the Class A Common
Stock, Class B-1 Common Stock, Class B-2 Common Stock, Class B-3 Common Stock
and Class B-4 Common Stock, respectively, outstanding as of the Effective
Date, until the Distribution Date, the Rights will be evidenced by such
certificates for the respective classes Common Stock and the registered
holders of the Common Stock shall also be the registered holders of the
associated Rights. Until the earlier of the Distribution Date or the
Expiration Date (as such term is defined in Section 7 hereof), the transfer
of any certificates representing shares of Common Stock in respect of which
Rights have been issued shall also constitute the transfer of the Rights
associated with such shares of Common Stock.

                  (c) Rights shall be issued in respect of all shares of
Common Stock which are issued (whether originally issued or from the
Company's treasury) on

                                       6
<Page>

or after the Effective Date (including all shares of Common Stock that are
issued pursuant to the Merger) but prior to the earlier of the Distribution
Date or the Expiration Date or in certain circumstances provided in Section
22 hereof, after the Distribution Date. Certificates representing such shares
of Class A Common Stock, Class B-1 Common Stock, Class B-2 Common Stock,
Class B-3 Common Stock and Class B-4 Common Stock shall also be deemed to be
certificates for the associated Rights, and shall bear the following legend:

            This certificate also evidences and entitles the holder hereof to
      certain Rights as set forth in the Rights Agreement between Chicago
      Mercantile Exchange Holdings Inc. (the "Company") and Mellon Investor
      Services LLC (the "Rights Agent") dated as of             , 2001, as
      amended from time to time (the "Rights Agreement"), the terms of which are
      hereby incorporated herein by reference and a copy of which is on file at
      the principal offices of Chicago Mercantile Exchange Holdings Inc. Under
      certain circumstances, as set forth in the Rights Agreement, such Rights
      will be evidenced by separate certificates and will no longer be evidenced
      by this certificate. Chicago Mercantile Exchange Holdings Inc. will mail
      to the holder of this certificate a copy of the Rights Agreement, as in
      effect on the date of mailing, without charge promptly after receipt of a
      written request therefor. Under certain circumstances set forth in the
      Rights Agreement, Rights issued to, or held by, any Person who is, was or
      becomes an Acquiring Person or any Affiliate or Associate thereof (as such
      terms are defined in the Rights Agreement), whether currently held by or
      on behalf of such Person or by any subsequent holder, may become null and
      void.

With respect to such certificates containing the foregoing legend, until the
earlier of (i) the Distribution Date or (ii) the Expiration Date, the Rights
associated with the Common Stock represented by such certificates shall be
evidenced by such certificates alone and registered holders of Common Stock
shall also be the registered holders of the associated Rights, and the transfer
of any of such certificates shall also constitute the transfer of the Rights
associated with the Common Stock represented by such certificates.

            SECTION 4. FORM OF RIGHTS CERTIFICATES.

                  (a) The Rights Certificates (and the forms of election to
purchase and of assignment to be printed on the reverse thereof) shall each be
substantially in the form set forth in Exhibit B hereto and may have such marks
of

                                       7
<Page>

identification or designation and such legends, summaries or endorsements
printed thereon as the Company may deem appropriate and as are not
inconsistent with the provisions of this Agreement, or as may be required to
comply with any applicable law or with any rule or regulation made pursuant
thereto or with any rule or regulation of any stock exchange on which the
Rights may from time to time be listed, or to conform to usage. Subject to
the provisions of Section 11 and Section 22 hereof, the Rights Certificates,
whenever distributed, shall be dated as of the Effective Date and on their
face shall entitle the holders thereof to purchase such number of one
one-thousandths of a share of Preferred Stock as shall be set forth therein
at the price set forth therein (such exercise price per one one-thousandth of
a share, the "Purchase Price"), but the amount and type of securities
purchasable upon the exercise of each Right and the Purchase Price thereof
shall be subject to adjustment as provided herein.

                  (b) Any Rights Certificate issued pursuant to Section 3(a)
or Section 22 hereof that represents Rights beneficially owned by: (i) an
Acquiring Person or any Associate or Affiliate of an Acquiring Person, (ii) a
transferee of an Acquiring Person (or of any such Associate or Affiliate) who
becomes a transferee after the Acquiring Person becomes such, or (iii) a
transferee of an Acquiring Person (or of any such Associate or Affiliate) who
becomes a transferee prior to or concurrently with the Acquiring Person
becoming such and receives such Rights pursuant to either (A) a transfer
(whether or not for consideration) from the Acquiring Person to holders of
equity interests in such Acquiring Person or to any Person with whom such
Acquiring Person has any continuing agreement, arrangement or understanding
regarding the transferred Rights or (B) a transfer which the Board of
Directors of the Company has determined is part of a plan, arrangement or
understanding which has as a primary purpose or effect avoidance of Section
7(e) hereof, and any Rights Certificate issued pursuant to Section 6 or
Section 11 hereof upon transfer, exchange, replacement or adjustment of any
other Rights Certificate referred to in this sentence, shall contain (to the
extent feasible) the following legend:

            The Rights represented by this Rights Certificate are or were
      beneficially owned by a Person who was or became an Acquiring Person or an
      Affiliate or Associate of an Acquiring Person (as such terms are defined
      in the Rights Agreement). Accordingly, this Rights Certificate and the
      Rights represented hereby may become null and void in the circumstances
      specified in Section 7(e) of such Agreement.

                                       8
<Page>

            SECTION 5. COUNTERSIGNATURE AND REGISTRATION.

                  (a) The Rights Certificates shall be executed on behalf of
the Company by its Chairman of the Board, its President or any Managing
Director, either manually or by facsimile signature, and shall have affixed
thereto the Company's seal or a facsimile thereof which shall be attested by
the Secretary or an Assistant Secretary of the Company, either manually or by
facsimile signature. The Rights Certificates shall be countersigned by the
Rights Agent, either manually or by facsimile signature and shall not be
valid for any purpose unless so countersigned. In case any officer of the
Company who shall have signed any of the Rights Certificates shall cease to
be such officer of the Company before countersignature by the Rights Agent
and issuance and delivery by the Company, such Rights Certificates,
nevertheless, may be countersigned by the Rights Agent and issued and
delivered by the Company with the same force and effect as though the person
who signed such Rights Certificates had not ceased to be such officer of the
Company; and any Rights Certificates may be signed on behalf of the Company
by any person who, at the actual date of the execution of such Rights
Certificate, shall be a proper officer of the Company to sign such Rights
Certificate, although at the date of the execution of this Rights Agreement
any such person was not such an officer.

                  (b) Following the Distribution Date, the Rights Agent will
keep or cause to be kept, at its principal office or offices designated as
the appropriate place for surrender of Rights Certificates upon exercise or
transfer, books for registration and transfer of the Rights Certificates
issued hereunder. Such books shall show the names and addresses of the
respective holders of the Rights Certificates, the number of Rights evidenced
on its face by each of the Rights Certificates and the date of each of the
Rights Certificates.

            SECTION 6. TRANSFER, SPLIT UP, COMBINATION AND EXCHANGE OF RIGHTS
CERTIFICATES; MUTILATED, DESTROYED, LOST OR STOLEN RIGHTS CERTIFICATES.

                  (a) Subject to the provisions of Section 4(b), Section 7(e)
and Section 14 hereof, at any time after the Close of Business on the
Distribution Date, and at or prior to the Close of Business on the Expiration
Date, any Rights Certificate or Certificates (other than Rights Certificates
representing Rights that have been exchanged pursuant to Section 24 hereof)
may be transferred, split up, combined or exchanged for another Rights
Certificate or Certificates, entitling the registered holder to purchase a
like number of one one-thousandths of a share of Preferred Stock (or,
following a Triggering Event, Common Stock, other securities, cash or other
assets, as the case may be) as the Rights Certificate or Certificates
surrendered then entitled such holder (or former holder in the case of a
transfer) to purchase. Any registered holder desiring to transfer, split up,
combine or exchange any Rights Cer-

                                       9
<Page>

tificate or Certificates shall make such request in writing delivered to the
Rights Agent, and shall surrender the Rights Certificate or Certificates to
be transferred, split up, combined or exchanged at the principal office or
offices of the Rights Agent designated for such purpose. Neither the Rights
Agent nor the Company shall be obligated to take any action whatsoever with
respect to the transfer of any such surrendered Rights Certificate until the
registered holder shall have completed and signed the certificate contained
in the form of assignment on the reverse side of such Rights Certificate and
shall have provided such additional evidence of the identity of the
Beneficial Owner (or former Beneficial Owner) or Affiliates or Associates
thereof as the Company shall reasonably request. Thereupon the Rights Agent
shall, subject to Section 4(b), Section 7(e), Section 14 and Section 24
hereof, countersign and deliver to the Person entitled thereto a Rights
Certificate or Rights Certificates, as the case may be, as so requested. The
Company may require payment of a sum sufficient to cover any tax or
governmental charge that may be imposed in connection with any transfer,
split up, combination or exchange of Rights Certificates.

                  (b) Upon receipt by the Company and the Rights Agent of
evidence reasonably satisfactory to them of the loss, theft, destruction or
mutilation of a Rights Certificate, and, in case of loss, theft or
destruction, of indemnity or security reasonably satisfactory to them, and
reimbursement to the Company and the Rights Agent of all reasonable expenses
incidental thereto, and upon surrender to the Rights Agent and cancellation
of the Rights Certificate if mutilated, the Company will execute and deliver
a new Rights Certificate of like tenor to the Rights Agent for
countersignature and delivery to the registered owner in lieu of the Rights
Certificate so lost, stolen, destroyed or mutilated.

            SECTION 7. EXERCISE OF RIGHTS; PURCHASE PRICE; EXPIRATION DATE OF
RIGHTS.

                  (a) Subject to Section 7(e) hereof, the registered holder
of any Rights Certificate may exercise the Rights evidenced thereby (except
as otherwise provided herein including, without limitation, the restrictions
on exercisability set forth in Section 9(c), Section 11(a)(iii) and Section
23(a) hereof) in whole or in part at any time after the Distribution Date
upon surrender of the Rights Certificate, with the form of election to
purchase and the certificate on the reverse side thereof duly executed, to
the Rights Agent at the principal office or offices of the Rights Agent
designated for such purpose, together with payment of the aggregate Purchase
Price with respect to the total number of one one-thousandths of a share (or
other securities, cash or other assets, as the case may be) as to which such
surrendered Rights are then exercisable, at or prior to the earlier of (i)
the Close of Business on November 15, 2011 (the "Final Expiration Date"),
(ii) the time at which the Rights are redeemed as provided in Section 23
hereof, or (iii) the time at which such Rights are exchanged

                                       10
<Page>

pursuant to Section 24 hereof (the earlier of (i), (ii) and (iii) being
herein referred to as the "Expiration Date").

                  (b) The Purchase Price for each one one-thousandth of a
share of Preferred Stock pursuant to the exercise of a Right shall initially
be $105, and shall be subject to adjustment from time to time as provided in
Sections 11 and 13(a) hereof and shall be payable in accordance with
paragraph (c) below.

                  (c) Upon receipt of a Rights Certificate representing
exercisable Rights, with the form of election to purchase and the certificate
duly executed, accompanied by payment, with respect to each Right so
exercised, of the Purchase Price per one one-thousandth of a share of
Preferred Stock (or other shares, securities, cash or other assets, as the
case may be) to be purchased as set forth below and an amount equal to any
applicable transfer tax, the Rights Agent shall, subject to Section 20(k)
hereof, thereupon promptly (i) (A) requisition from any transfer agent of the
shares of Preferred Stock (or make available, if the Rights Agent is the
transfer agent for such shares) certificates for the total number of one
one-thousandths of a share of Preferred Stock to be purchased and the Company
hereby irrevocably authorizes its transfer agent to comply with all such
requests, or (B) if the Company shall have elected to deposit the total
number of shares of Preferred Stock issuable upon exercise of the Rights
hereunder with a depositary agent, requisition from the depositary agent
depositary receipts representing such number of one one-thousandths of a
share of Preferred Stock as are to be purchased (in which case certificates
for the shares of Preferred Stock represented by such receipts shall be
deposited by the transfer agent with the depositary agent) and the Company
will direct the depositary agent to comply with such request, (ii)
requisition from the Company the amount of cash, if any, to be paid in lieu
of fractional shares in accordance with Section 14 hereof, (iii) after
receipt of such certificates or depositary receipts, cause the same to be
delivered to or upon the order of the registered holder of such Rights
Certificate, registered in such name or names as may be designated by such
holder, and (iv) after receipt thereof, deliver such cash, if any, to or upon
the order of the registered holder of such Rights Certificate. The payment of
the Purchase Price (as such amount may be reduced pursuant to Section
11(a)(iii) hereof) shall be made in cash or by certified bank check or bank
draft payable to the order of the Company. In the event that the Company is
obligated to issue other securities (including Common Stock) of the Company,
pay cash and/or distribute other property pursuant to Section 11(a) hereof,
the Company will make all arrangements necessary so that such other
securities, cash and/or other property are available for distribution by the
Rights Agent, if and when appropriate. The Company reserves the right to
require prior to the occurrence of a Triggering Event that, upon any exercise
of Rights, a number of Rights be exercised so that only whole shares of
Preferred Stock would be issued.

                                       11
<Page>

                  (d) In case the registered holder of any Rights Certificate
shall exercise less than all the Rights evidenced thereby, a new Rights
Certificate evidencing Rights equivalent to the Rights remaining unexercised
shall be issued by the Rights Agent and delivered to, or upon the order of,
the registered holder of such Rights Certificate, registered in such name or
names as may be designated by such holder, subject to the provisions of
Section 14 hereof.

                  (e) Notwithstanding anything in this Agreement to the
contrary, from and after the first occurrence of a Section 11(a)(ii) Event,
any Rights beneficially owned by (i) an Acquiring Person or an Associate or
Affiliate of an Acquiring Person, (ii) a transferee of an Acquiring Person
(or of any such Associate or Affiliate) who becomes a transferee after the
Acquiring Person becomes such, or (iii) a transferee of an Acquiring Person
(or of any such Associate or Affiliate) who becomes a transferee prior to or
concurrently with the Acquiring Person becoming such and receives such Rights
pursuant to either (A) a transfer (whether or not for consideration) from the
Acquiring Person to holders of equity interests in such Acquiring Person or
to any Person with whom the Acquiring Person has any continuing agreement,
arrangement or understanding regarding the transferred Rights or (B) a
transfer which the Board of Directors of the Company has determined is part
of a plan, arrangement or understanding which has as a primary purpose or
effect the avoidance of this Section 7(e), shall become null and void without
any further action and no holder of such Rights shall have any rights
whatsoever with respect to such Rights, whether under any provision of this
Agreement or otherwise. The Company shall use all reasonable efforts to
insure that the provisions of this Section 7(e) and Section 4(b) hereof are
complied with, but shall have no liability to any holder of Rights
Certificates or other Person as a result of its failure to make any
determinations with respect to an Acquiring Person or its Affiliates,
Associates or transferees hereunder.

                  (f) Notwithstanding anything in this Agreement to the
contrary, neither the Rights Agent nor the Company shall be obligated to
undertake any action with respect to a registered holder upon the occurrence
of any purported exercise as set forth in this Section 7 unless such
registered holder shall have (i) completed and signed the certificate
contained in the form of election to purchase set forth on the reverse side
of the Rights Certificate surrendered for such exercise, and (ii) provided
such additional evidence of the identity of the Beneficial Owner (or former
Beneficial Owner) or Affiliates or Associates thereof as the Company shall
reasonably request.

            Section 8. CANCELLATION AND DESTRUCTION OF RIGHTS CERTIFICATES.
All Rights Certificates surrendered for the purpose of exercise, transfer,
split up, combination or exchange shall, if surrendered to the Company or any
of its agents, be

                                      12
<Page>

delivered to the Rights Agent for cancellation or in cancelled form, or, if
surrendered to the Rights Agent, shall be cancelled by it, and no Rights
Certificates shall be issued in lieu thereof except as expressly permitted by
any of the provisions of this Agreement. The Company shall deliver to the
Rights Agent for cancellation and retirement, and the Rights Agent shall so
cancel and retire, any other Rights Certificate purchased or acquired by the
Company otherwise than upon the exercise thereof. The Rights Agent shall
deliver all cancelled Rights Certificates to the Company, or shall, at the
written request of the Company, destroy such cancelled Rights Certificates,
and in such case shall deliver a certificate of destruction thereof to the
Company.

            SECTION 9. RESERVATION AND AVAILABILITY OF CAPITAL STOCK.

                  (a) The Company covenants and agrees that it will cause to
be reserved and kept available out of its authorized and unissued shares of
Preferred Stock (and, following the occurrence of a Triggering Event, out of
its authorized and unissued shares of Class A Common Stock and/or other
securities or out of its authorized and issued shares held in its treasury),
the number of shares of Preferred Stock (and, following the occurrence of a
Triggering Event, Class A Common Stock and/or other securities) that, as
provided in this Agreement including Section 11(a)(iii) hereof, will be
sufficient to permit the exercise in full of all outstanding Rights.

                  (b) So long as the shares of Preferred Stock (and,
following the occurrence of a Triggering Event, Class A Common Stock and/or
other securities) issuable and deliverable upon the exercise of the Rights
may be listed on any national securities exchange, the Company shall use its
best efforts to cause, from and after such time as the Rights become
exercisable, all shares reserved for such issuance to be listed on such
exchange upon official notice of issuance upon such exercise.

                  (c) The Company shall use its best efforts to (i) file, as
soon as practicable following the earliest date after the first occurrence of
a Section 11(a)(ii) Event on which the consideration to be delivered by the
Company upon exercise of the Rights has been determined in accordance with
Section 11(a)(iii) hereof, a registration statement under the Securities Act
of 1933 (the "Act"), with respect to the securities purchasable upon exercise
of the Rights on an appropriate form, (ii) cause such registration statement
to become effective as soon as practicable after such filing, and (iii) cause
such registration statement to remain effective (with a prospectus at all
times meeting the requirements of the Act) until the earlier of (A) the date
as of which the Rights are no longer exercisable for such securities, and (B)
the Expiration Date. The Company will also take such action as may be
appropriate under, or to ensure compliance with, the securities or "blue sky"
laws of the various

                                       13
<Page>

states in connection with the exercisability of the Rights. The Company may
temporarily suspend, for a period of time not to exceed ninety (90) days
after the date set forth in clause (i) of the first sentence of this Section
9(c), the exercisability of the Rights in order to prepare and file such
registration statement and permit it to become effective. Upon any such
suspension, the Company shall issue a public announcement stating that the
exercisability of the Rights has been temporarily suspended, as well as a
public announcement at such time as the suspension is no longer in effect. In
addition, if the Company shall determine that a registration statement is
required following the Distribution Date, the Company may temporarily suspend
the exercisability of the Rights until such time as a registration statement
has been declared effective. Notwithstanding any provision of this Agreement
to the contrary, the Rights shall not be exercisable in any jurisdiction if
the requisite qualification in such jurisdiction shall not have been
obtained, the exercise thereof shall not be permitted under applicable law or
a registration statement shall not have been declared effective.

                  (d) The Company covenants and agrees that it will take all
such action as may be necessary to ensure that all one one-thousandths of a
share of Preferred Stock (and, following the occurrence of a Triggering
Event, shares of Class A Common Stock and/or other securities) delivered upon
exercise of Rights shall, at the time of delivery of the certificates for
such shares (subject to payment of the Purchase Price), be duly and validly
authorized and issued and fully paid and nonassessable.

                  (e) The Company further covenants and agrees that it will
pay when due and payable any and all federal and state transfer taxes and
charges which may be payable in respect of the issuance or delivery of the
Rights Certificates and of any certificates for a number of one
one-thousandths of a share of Preferred Stock (or Class A Common Stock and/or
other securities, as the case may be) upon the exercise of Rights. The
Company shall not, however, be required to pay any transfer tax which may be
payable in respect of any transfer or delivery of Rights Certificates to a
Person other than, or the issuance or delivery of a number of one
one-thousandths of a share of Preferred Stock (or Class A Common Stock and/or
other securities, as the case may be) in respect of a name other than that
of, the registered holder of the Rights Certificates evidencing Rights
surrendered for exercise or to issue or deliver any certificates for a number
of one one-thousandths of a share of Preferred Stock (or Class A Common Stock
and/or other securities, as the case may be) in a name other than that of the
registered holder upon the exercise of any Rights until such tax shall have
been paid (any such tax being payable by the holder of such Rights
Certificate at the time of surrender) or until it has been established to the
Company's satisfaction that no such tax is due.

                                       14
<Page>

            Section 10. PREFERRED STOCK RECORD DATE. Each person in whose
name any certificate for a number of one one-thousandths of a share of
Preferred Stock (or Class A Common Stock and/or other securities, as the case
may be) is issued upon the exercise of Rights shall for all purposes be
deemed to have become the holder of record of such fractional shares of
Preferred Stock (or Class A Common Stock and/or other securities, as the case
may be) represented thereby on, and such certificate shall be dated, the date
upon which the Rights Certificate evidencing such Rights was duly surrendered
and payment of the Purchase Price (and all applicable transfer taxes) was
made; provided, however, that if the date of such surrender and payment is a
date upon which the Preferred Stock (or Class A Common Stock and/or other
securities, as the case may be) transfer books of the Company are closed,
such Person shall be deemed to have become the record holder of such shares
(fractional or otherwise) on, and such certificate shall be dated, the next
succeeding Business Day on which the Preferred Stock (or Class A Common Stock
and/or other securities, as the case may be) transfer books of the Company
are open. Prior to the exercise of the Rights evidenced thereby, the holder
of a Rights Certificate shall not be entitled to any rights of a shareholder
of the Company with respect to shares for which the Rights shall be
exercisable, including, without limitation, the right to vote, to receive
dividends or other distributions or to exercise any preemptive rights, and
shall not be entitled to receive any notice of any proceedings of the
Company, except as provided herein.

            Section 11. ADJUSTMENT OF PURCHASE PRICE, NUMBER AND KIND OF
SHARES OR NUMBER OF RIGHTS. The Purchase Price, the number and kind of shares
covered by each Right and the number of Rights outstanding are subject to
adjustment from time to time as provided in this Section 11.

                           (a) (i) In the event the Company shall at any time
      after the date of this Agreement (A) declare a dividend on the Preferred
      Stock payable in shares of Preferred Stock, (B) subdivide the outstanding
      Preferred Stock, (C) combine the outstanding Preferred Stock into a
      smaller number of shares, or (D) issue any shares of its capital stock in
      a reclassification of the Preferred Stock (including any such
      reclassification in connection with a consolidation or merger in which the
      Company is the continuing or surviving corporation), except as otherwise
      provided in this Section 11(a) and Section 7(e) hereof, the Purchase Price
      in effect at the time of the record date for such dividend or of the
      effective date of such subdivision, combination or reclassification, and
      the number and kind of shares of Preferred Stock or capital stock, as the
      case may be, issuable on such date, shall be proportionately adjusted so
      that the holder of any Right exercised after such time shall be entitled
      to receive, upon payment of the Purchase Price then in effect, the
      aggregate number and kind of shares of Preferred Stock or capital stock,
      as the case may be, which, if such Right had been exercised

                                       15
<Page>

      immediately prior to such date and at a time when the Preferred Stock
      transfer books of the Company were open, he or she would have owned upon
      such exercise and been entitled to receive by virtue of such dividend,
      subdivision, combination or reclassification. If an event occurs which
      would require an adjustment under both this Section 11(a)(i) and
      Section 11(a)(ii) hereof, the adjustment provided for in this Section
      11(a)(i) shall be in addition to, and shall be made prior to, any
      adjustment required pursuant to Section 11(a)(ii) hereof.

                           (ii) In the event that any Person, at any time
      after the Effective Date, shall become an Acquiring Person, unless the
      event causing such person to become an Acquiring Person is a transaction
      set forth in Section 13(a) hereof, or is an acquisition of shares of
      Common Stock pursuant to a tender offer or an exchange offer for all
      outstanding shares of Common Stock at a price and on terms determined
      by at least a majority of the members of the Board of Directors who are
      not officers of the Company and who are not representatives, nominees,
      Affiliates or Associates of an Acquiring Person, after receiving advice
      from one or more investment banking firms, to be (a) at a price which is
      fair to shareholders (taking into account all factors which such members
      of the Board deem relevant including, without limitation, prices which
      could reasonably be achieved if the Company or its assets were sold on an
      orderly basis designed to realize maximum value) and (b) otherwise in the
      best interests of the Company and its shareholders (hereinafter, a
      "Qualifying Offer"), then, promptly following the occurrence of any such
      event, proper provision shall be made so that each holder of a Right,
      (except, as provided below and in Section 7(e) hereof) shall thereafter
      have the right to receive, upon exercise thereof at the then current
      Purchase Price in accordance with the terms of this Agreement, in lieu of
      a number of one one-thousandths of a share of Preferred Stock, such number
      of shares of Class A Common Stock of the Company as shall equal the result
      obtained by (x) multiplying the then current Purchase Price by the then
      number of one one-thousandths of a share of Preferred Stock for which a
      Right was exercisable immediately prior to the first occurrence of a
      Section 11(a)(ii) Event, and (y) dividing that product (which, following
      such first occurrence, shall thereafter be referred to as the "Purchase
      Price" for each Right and for all purposes of this Agreement) by 50% of
      the Current Market Price (determined pursuant to Section 11(d) hereof) per
      share of Class A Common Stock for which a Right is exercisable on the date
      of such first occurrence (such number of shares, the "Adjustment Shares").

                                       16
<Page>

                        (iii) In the event that the number of shares of Class A
      Common Stock which are authorized by the Company's Amended and Restated
      Certificate of Incorporation but not outstanding or reserved for issuance
      for purposes other than upon exercise of the Rights are not sufficient to
      permit the exercise in full of the Rights in accordance with the foregoing
      subparagraph (ii) of this Section 11(a), the Company shall (A) determine
      the value of the Adjustment Shares issuable upon the exercise of a Right
      (the "Current Value"), and (B) with respect to each Right (subject to
      Section 7(e) hereof), make adequate provision to substitute for the
      Adjustment Shares, upon the exercise of a Right and payment of the
      applicable Purchase Price, (1) cash, (2) a reduction in the Purchase
      Price, (3) Class A Common Stock or other equity securities of the Company
      (including, without limitation, shares, or units of shares, of preferred
      stock, such as the Preferred Stock, which the Board has deemed to have
      essentially the same value or economic rights as shares of Class A Common
      Stock (such shares of preferred stock being referred to as "Common Stock
      Equivalents")), (4) debt securities of the Company, (5) other assets, or
      (6) any combination of the foregoing, having an aggregate value equal to
      the Current Value (less the amount of any reduction in the Purchase
      Price), where such aggregate value has been determined by the Board based
      upon the advice of a nationally recognized investment banking firm
      selected by the Board; PROVIDED, however, that if the Company shall not
      have made adequate provision to deliver value pursuant to clause (B) above
      within thirty (30) days following the later of (x) the first occurrence of
      a Section 11(a)(ii) Event and (y) the date on which the Company's right of
      redemption pursuant to Section 23(a) expires (the later of (x) and (y)
      being referred to herein as the "Section 11(a)(ii) Trigger Date"), then
      the Company shall be obligated to deliver, upon the surrender for exercise
      of a Right and without requiring payment of the Purchase Price, shares of
      Class A Common Stock (to the extent available) and then, if necessary,
      cash or shares, which shares (of the Class A Common Stock for which a
      right is exercisable and/or the Common Stock) and/or cash have an
      aggregate value equal to the Spread. For purposes of the preceding
      sentence, the term "Spread" shall mean the excess of (i) the Current Value
      over (ii) the Purchase Price. If the Board determines in good faith that
      it is likely that sufficient additional shares of Class A Common Stock
      could be authorized for issuance upon exercise in full of the Rights, the
      thirty (30) day period set forth above may be extended to the extent
      necessary, but not more than ninety (90) days after the Section 11(a)(ii)
      Trigger Date, in order that the Company may seek

                                        17
<Page>

      shareholder approval for the authorization of such additional shares
      (such thirty (30) day period, as it may be extended, is herein called
      the "Substitution Period"). To the extent that action is to be taken
      pursuant to the first and/or third sentences of this Section 11(a)(iii),
      the Company (1) shall provide, subject to Section 7(e) hereof, that such
      action shall apply uniformly to all outstanding Rights, and (2) may
      suspend the exercisability of the Rights until the expiration of the
      Substitution Period in order to seek such shareholder approval for such
      authorization of additional shares and/or to decide the appropriate form
      of distribution to be made pursuant to such first sentence and to
      determine the value thereof. In the event of any such suspension, the
      Company shall issue a public announcement stating that the exercisability
      of the Rights has been temporarily suspended, as well as a public
      announcement at such time as the suspension is no longer in effect. For
      purposes of this Section 11(a)(iii), the value of each Adjustment Share
      shall be the Current Market Price per share of the Class A Common Stock
      on the Section 11(a)(ii) Trigger Date and the per share or per unit value
      of any Common Stock Equivalent shall be deemed to equal the Current Market
      Price per share of the Common Stock on such date.

                  (b) In case the Company shall fix a record date for the
issuance of rights, options or warrants to all holders of Preferred Stock
entitling them to subscribe for or purchase (for a period expiring within
forty-five (45) calendar days after such record date) Preferred Stock (or shares
having the same rights, privileges and preferences as the shares of Preferred
Stock ("equivalent preferred stock")) or securities convertible into Preferred
Stock or equivalent preferred stock at a price per share of Preferred Stock or
per share of equivalent preferred stock (or having a conversion price per share,
if a security convertible into Preferred Stock or equivalent preferred stock)
less than the Current Market Price (as determined pursuant to Section 11(d)
hereof) per share of Preferred Stock on such record date, the Purchase Price to
be in effect after such record date shall be determined by multiplying the
Purchase Price in effect immediately prior to such record date by a fraction,
the numerator of which shall be the number of shares of Preferred Stock
outstanding on such record date, plus the number of shares of Preferred Stock
which the aggregate offering price of the total number of shares of Preferred
Stock and/or equivalent preferred stock so to be offered (and/or the aggregate
initial conversion price of the convertible securities so to be offered) would
purchase at such Current Market Price, and the denominator of which shall be the
number of shares of Preferred Stock outstanding on such record date, plus the
number of additional shares of Preferred Stock and/or equivalent preferred stock
to be offered for subscription or purchase (or into which the convertible
securities so to be offered are initially

                                       18
<Page>

convertible). In case such subscription price may be paid by delivery of
consideration part or all of which may be in a form other than cash, the
value of such consideration shall be as determined in good faith by the Board
of Directors of the Company, whose determination shall be described in a
statement filed with the Rights Agent and shall be binding on the Rights
Agent and the holders of the Rights. Shares of Preferred Stock owned by or
held for the account of the Company shall not be deemed outstanding for the
purpose of any such computation. Such adjustment shall be made successively
whenever such a record date is fixed, and in the event that such rights or
warrants are not so issued, the Purchase Price shall be adjusted to be the
Purchase Price which would then be in effect if such record date had not been
fixed.

                  (c) In case the Company shall fix a record date for a
distribution to all holders of Preferred Stock (including any such
distribution made in connection with a consolidation or merger in which the
Company is the continuing corporation) of evidences of indebtedness, cash
(other than a regular periodic cash dividend out of the earnings or retained
earnings of the Company), assets (other than a dividend payable in Preferred
Stock, but including any dividend payable in stock other than Preferred
Stock) or subscription rights or warrants (excluding those referred to in
Section 11(b) hereof), the Purchase Price to be in effect after such record
date shall be determined by multiplying the Purchase Price in effect
immediately prior to such record date by a fraction, the numerator of which
shall be the Current Market Price (as determined pursuant to Section 11(d)
hereof) per share of Preferred Stock on such record date, less the fair
market value (as determined in good faith by the Board of Directors of the
Company, whose determination shall be described in a statement filed with the
Rights Agent) of the portion of the cash, assets or evidences of indebtedness
so to be distributed or of such subscription rights or warrants applicable to
a share of Preferred Stock and the denominator of which shall be such Current
Market Price (as determined pursuant to Section 11(d) hereof) per share of
Preferred Stock. Such adjustments shall be made successively whenever such a
record date is fixed, and in the event that such distribution is not so made,
the Purchase Price shall be adjusted to be the Purchase Price which would
have been in effect if such record date had not been fixed.

                  (d) (i) For the purpose of any computation hereunder, other
than computations made pursuant to Section 11(a)(iii) hereof, the Current
Market Price per share of Class A Common Stock on any date shall be deemed to
be the average of the daily closing prices per share of such Class A Common
Stock for the thirty (30) consecutive Trading Days immediately prior to such
date, and for purposes of computations made pursuant to Section 11(a)(iii)
hereof, the Current Market Price per share of Class A Common Stock on any
date shall be deemed to be the average of the daily closing prices per share
of such Class A Common Stock for the ten (10) consecutive Trading Days
immediately following such date; PROVIDED, however, that

                                      19
<Page>

in the event that the Current Market Price per share of the Class A Common
Stock is determined during a period following the announcement by the issuer
of such Class A Common Stock of (A) a dividend or distribution on such Class
A Common Stock payable in shares of such Class A Common Stock or securities
convertible into shares of such Class A Common Stock (other than the Rights),
or (B) any subdivision, combination or reclassification of such Class A
Common Stock, and the ex-dividend date for such dividend or distribution, or
the record date for such subdivision, combination or reclassification shall
not have occurred prior to the commencement of the requisite thirty (30)
Trading Day or ten (10) Trading Day period, as set forth above, then, and in
each such case, the Current Market Price shall be properly adjusted to take
into account ex-dividend trading. The closing price for each day shall be the
last sale price, regular way, or, in case no such sale takes place on such
day, the average of the closing bid and asked prices, regular way, in either
case as reported in the principal consolidated transaction reporting system
with respect to securities listed or admitted to trading on the New York
Stock Exchange or, if the shares of Class A Common Stock are not listed or
admitted to trading on the New York Stock Exchange, as reported in the
principal consolidated transaction reporting system with respect to
securities listed on the principal national securities exchange on which the
shares of Class A Common Stock are listed or admitted to trading or, if the
shares of Class A Common Stock are not listed or admitted to trading on any
national securities exchange, the last quoted price or, if not so quoted, the
average of the high bid and low asked prices in the over-the-counter market,
as reported by the National Association of Securities Dealers, Inc. Automated
Quotation System or such other system then in use, or, if on any such date
the shares of Class A Common Stock are not quoted by any such organization,
the average of the closing bid and asked prices as furnished by a
professional market maker making a market in the Class A Common Stock
selected by the Board. If on any such date no market maker is making a market
in the Class A Common Stock, the fair value of such shares on such date as
determined in good faith by the Board shall be used. The term "Trading Day"
shall mean a day on which the principal national securities exchange on which
the shares of Class A Common Stock are listed or admitted to trading is open
for the transaction of business or, if the shares of Class A Common Stock are
not listed or admitted to trading on any national securities exchange, a
Business Day. If the Class A Common Stock is not publicly held or not so
listed or traded, Current Market Price per share shall mean the fair value
per share as determined in good faith by the Board, whose determination shall
be described in a statement filed with the Rights Agent and shall be
conclusive for all purposes.

                           (ii)     For the purpose of any computation
      hereunder, the Current Market Price per share of Preferred Stock shall be
      determined in the same manner as set forth above for the Class A Common
      Stock in clause (i) of this Section 11(d) (other than the last

                                       20
<Page>

      sentence thereof). If the Current Market Price per share of Preferred
      Stock cannot be determined in the manner provided above or if the
      Preferred Stock is not publicly held or listed or traded in a manner
      described in clause (i) of this Section 11(d), the Current Market Price
      per share of Preferred Stock shall be conclusively deemed to be an amount
      equal to 1,000 (as such number may be appropriately adjusted for such
      events as stock splits, stock dividends and recapitalizations with
      respect to the Class A Common Stock occurring after the date of this
      Agreement) multiplied by the Current Market Price per share of the Class A
      Common Stock. If neither the Class A Common Stock nor the Preferred Stock
      is publicly held or so listed or traded, Current Market Price per share of
      the Preferred Stock shall mean the fair value per share as determined in
      good faith by the Board, whose determination shall be described in a
      statement filed with the Rights Agent and shall be conclusive for all
      purposes. For all purposes of this Agreement, the Current Market Price of
      a Unit shall be equal to the Current Market Price of one share of
      Preferred Stock divided by 1,000.

                  (e) Anything herein to the contrary notwithstanding, no
adjustment in the Purchase Price shall be required unless such adjustment
would require an increase or decrease of at least one percent (1%) in the
Purchase Price; PROVIDED, however, that any adjustments which by reason of
this Section 11(e) are not required to be made shall be carried forward and
taken into account in any subsequent adjustment. All calculations under this
Section 11 shall be made to the nearest cent or to the nearest ten-thousandth
of a share of Common Stock or other share or one-ten millionth of a share of
Preferred Stock, as the case may be. Notwithstanding the first sentence of
this Section 11(e), any adjustment required by this Section 11 shall be made
no later than the earlier of (i) three (3) years from the date of the
transaction which mandates such adjustment, or (ii) the Expiration Date.

                  (f) If as a result of an adjustment made pursuant to
Section 11(a)(ii) or Section 13(a) hereof, the holder of any Right thereafter
exercised shall become entitled to receive any shares of capital stock other
than Preferred Stock, thereafter the number of such other shares so
receivable upon exercise of any Right and the Purchase Price thereof shall be
subject to adjustment from time to time in a manner and on terms as nearly
equivalent as practicable to the provisions with respect to the Preferred
Stock contained in Sections 11(a), (b), (c), (e), (g), (h), (i), (j), (k) and
(m), and the provisions of Sections 7, 9, 10, 13 and 14 hereof with respect
to the Preferred Stock shall apply on like terms to any such other shares.

                  (g) All Rights originally issued by the Company subsequent
to any adjustment made to the Purchase Price hereunder shall evidence the
right to

                                       21
<Page>

purchase, at the adjusted Purchase Price, the number of one one-thousandths
of a share of Preferred Stock purchasable from time to time hereunder upon
exercise of the Rights, all subject to further adjustment as provided herein.

                  (h) Unless the Company shall have exercised its election as
provided in Section 11(i), upon each adjustment of the Purchase Price as a
result of the calculations made in Sections 11(b) and (c), each Right
outstanding immediately prior to the making of such adjustment shall
thereafter evidence the right to purchase, at the adjusted Purchase Price,
that number of one one-thousandths of a share of Preferred Stock (calculated
to the nearest one-ten millionth) obtained by (i) multiplying (x) the number
of one one-thousandths of a share covered by a Right immediately prior to
this adjustment, by (y) the Purchase Price in effect immediately prior to
such adjustment of the Purchase Price, and (ii) dividing the product so
obtained by the Purchase Price in effect immediately after such adjustment of
the Purchase Price.

                  (i) The Company may elect on or after the date of any
adjustment of the Purchase Price to adjust the number of Rights, in lieu of
any adjustment in the number of one one-thousandths of a share of Preferred
Stock purchasable upon the exercise of a Right. Each of the Rights
outstanding after the adjustment in the number of Rights shall be exercisable
for the number of one one-thousandths of a share of Preferred Stock for which
a Right was exercisable immediately prior to such adjustment. Each Right held
of record prior to such adjustment of the number of Rights shall become that
number of Rights (calculated to the nearest one-ten-thousandth) obtained by
dividing the Purchase Price in effect immediately prior to adjustment of the
Purchase Price by the Purchase Price in effect immediately after adjustment
of the Purchase Price. The Company shall make a public announcement of its
election to adjust the number of Rights, indicating the record date for the
adjustment, and, if known at the time, the amount of the adjustment to be
made. This record date may be the date on which the Purchase Price is
adjusted or any day thereafter, but, if the Rights Certificates have been
issued, shall be at least ten (10) days later than the date of the public
announcement. If Rights Certificates have been issued, upon each adjustment
of the number of Rights pursuant to this Section 11(i), the Company shall, as
promptly as practicable, cause to be distributed to holders of record of
Rights Certificates on such record date Rights Certificates evidencing,
subject to Section 14 hereof, the additional Rights to which such holders
shall be entitled as a result of such adjustment, or, at the option of the
Company, shall cause to be distributed to such holders of record in
substitution and replacement for the Rights Certificates held by such holders
prior to the date of adjustment, and upon surrender thereof, if required by
the Company, new Rights Certificates evidencing all the Rights to which such
holders shall be entitled after such adjustment. Rights Certificates so to be
distributed shall be issued, executed and

                                       22
<Page>

countersigned in the manner provided for herein (and may bear, at the option
of the Company, the adjusted Purchase Price) and shall be registered in the
names of the holders of record of Rights Certificates on the record date
specified in the public announcement.

                  (j) Irrespective of any adjustment or change in the
Purchase Price or the number of one one-thousandth of a share of Preferred
Stock issuable upon the exercise of the Rights, the Rights Certificates
theretofore and thereafter issued may continue to express the Purchase Price
per one one-thousandth of a share and the number of one one-thousandth of a
share which were expressed in the initial Rights Certificates issued
hereunder.

                  (k) Before taking any action that would cause an adjustment
reducing the Purchase Price below the then stated value, if any, of the
number of one one-thousandths of a share of Preferred Stock issuable upon
exercise of the Rights, the Company shall take any corporate action which
may, in the opinion of its counsel, be necessary in order that the Company
may validly and legally issue fully paid and nonassessable such number of one
one-thousandth of a share of Preferred Stock at such adjusted Purchase Price.

                  (l) In any case in which this Section 11 shall require that
an adjustment in the Purchase Price be made effective as of a record date for
a specified event, the Company may elect to defer until the occurrence of
such event the issuance to the holder of any Right exercised after such
record date the number of one one-thousandths of a share of Preferred Stock
and other capital stock or securities of the Company, if any, issuable upon
such exercise over and above the number of one one-thousandths of a share of
Preferred Stock and other capital stock or securities of the Company, if any,
issuable upon such exercise on the basis of the Purchase Price in effect
prior to such adjustment; PROVIDED, however, that the Company shall deliver
to such holder a due bill or other appropriate instrument evidencing such
holder's right to receive such additional shares (fractional or otherwise) or
securities upon the occurrence of the event requiring such adjustment.

                  (m) Anything in this Section 11 to the contrary
notwithstanding, the Company shall be entitled to make such reductions in the
Purchase Price, in addition to those adjustments expressly required by this
Section 11, as and to the extent that in their good faith judgment the Board
of Directors of the Company shall determine to be advisable in order that any
(i) consolidation or subdivision of the Preferred Stock, (ii) issuance wholly
for cash of any shares of Preferred Stock at less than the current market
price, (iii) issuance wholly for cash of shares of Preferred Stock or
securities which by their terms are convertible into or exchangeable for
shares of Preferred Stock, (iv) stock dividends or (v) issuance of

                                       23
<Page>

rights, options or warrants referred to in this Section 11, hereafter made by
the Company to holders of its Preferred Stock shall not be taxable to such
shareholders.

                  (n) The Company covenants and agrees that it shall not, at
any time after the Distribution Date, (i) consolidate with any other Person
(other than a Subsidiary of the Company in a transaction which complies with
Section 11(o) hereof), (ii) merge with or into any other Person (other than a
Subsidiary of the Company in a transaction which complies with Section 11(o)
hereof), or (iii) sell or transfer (or permit any Subsidiary to sell or
transfer), in one transaction, or a series of related transactions, assets or
earning power aggregating more than 50% of the assets or earning power of the
Company and its Subsidiaries (taken as a whole) to any other Person or
Persons (other than the Company and/or any of its Subsidiaries in one or more
transactions each of which complies with Section 11(o) hereof), if (x) at the
time of or immediately after such consolidation, merger or sale there are any
rights, warrants or other instruments or securities outstanding or agreements
in effect which would substantially diminish or otherwise eliminate the
benefits intended to be afforded by the Rights or (y) prior to,
simultaneously with or immediately after such consolidation, merger or sale,
the shareholders of the Person who constitutes, or would constitute, the
"Principal Party" for purposes of Section 13(a) hereof shall have received a
distribution of Rights previously owned by such Person or any of its
Affiliates and Associates.

                  (o) The Company covenants and agrees that, after the
Distribution Date, it will not, except as permitted by Section 23, Section 24
or Section 27 hereof, take (or permit any Subsidiary to take) any action if
at the time such action is taken it is reasonably foreseeable that such
action will diminish substantially or otherwise eliminate the benefits
intended to be afforded by the Rights.

                  (p) Anything in this Agreement to the contrary
notwithstanding, in the event that the Company shall at any time after the
Effective Date and prior to the Distribution Date (i) declare a dividend on
the outstanding shares of Common Stock payable in shares of Common Stock,
(ii) subdivide the outstanding shares of Common Stock, or (iii) combine the
outstanding shares of Common Stock into a smaller number of shares, the
number of Rights associated with each share of Common Stock then outstanding,
or issued or delivered thereafter but prior to the Distribution Date, shall
be proportionately adjusted so that the number of Rights thereafter
associated with each share of Common Stock following any such event shall
equal the result obtained by multiplying the number of Rights associated with
each share of Common Stock immediately prior to such event by a fraction the
numerator which shall be the total number of shares of Common Stock
outstanding immediately prior to the occurrence of the event and the
denominator of which shall

                                       24
<Page>

be the total number of shares of Common Stock outstanding immediately
following the occurrence of such event.

            Section 12. CERTIFICATE OF ADJUSTED PURCHASE PRICE OR NUMBER OF
SHARES. Whenever an adjustment is made as provided in Section 11 and Section
13 hereof, the Company shall (a) promptly prepare a certificate setting forth
such adjustment and a brief statement of the facts accounting for such
adjustment, (b) promptly file with the Rights Agent, and with each transfer
agent for the Preferred Stock and the Common Stock, a copy of such
certificate, and (c) mail a brief summary thereof to each holder of a Rights
Certificate (or, if prior to the Distribution Date, to each holder of a
certificate representing shares of Common Stock) in accordance with Section
25 hereof. The Rights Agent shall be fully protected in relying on any such
certificate and on any adjustment therein contained.

            SECTION 13. CONSOLIDATION, MERGER OR SALE OR TRANSFER OF ASSETS
OR EARNING POWER.

                  (a) In the event that, following the Stock Acquisition
Date, directly or indirectly, (x) the Company shall consolidate with, or
merge with and into, any other Person (other than a Subsidiary of the Company
in a transaction which complies with Section 11(o) hereof), and the Company
shall not be the continuing or surviving corporation of such consolidation or
merger, (y) any Person (other than a Subsidiary of the Company in a
transaction which complies with Section 11(o) hereof) shall consolidate with,
or merge with or into, the Company, and the Company shall be the continuing
or surviving corporation of such consolidation or merger and, in connection
with such consolidation or merger, all or part of the outstanding shares of
Class A Common Stock shall be changed into or exchanged for stock or other
securities of any other Person or cash or any other property, or (z) the
Company shall sell or otherwise transfer (or one or more of its Subsidiaries
shall sell or otherwise transfer), in one transaction or a series of related
transactions, assets or earning power aggregating more than 50% of the assets
or earning power of the Company and its Subsidiaries (taken as a whole) to
any Person or Persons (other than the Company or any Subsidiary of the
Company in one or more transactions each of which complies with Section 11(o)
hereof), then, and in each such case (except as may be contemplated by
Section 13(d) hereof), proper provision shall be made so that: (i) each
holder of a Right, except as provided in Section 7(e) hereof, shall
thereafter have the right to receive, upon the exercise thereof at the then
current Purchase Price in accordance with the terms of this Agreement, such
number of validly authorized and issued, fully paid, non-assessable and
freely tradeable shares of Common Stock of the Principal Party (as such term
is hereinafter defined), not subject to any liens, encumbrances, rights of
first refusal or other adverse claims, as shall be equal to the result
obtained by (1) multiplying the then current Purchase Price by the number of

                                       25
<Page>

one one-thousandths of a share of Preferred Stock for which a Right is
exercisable immediately prior to the first occurrence of a Section 13 Event
(or, if a Section 11(a)(ii) Event has occurred prior to the first occurrence
of a Section 13 Event, multiplying the number of such one one-thousandths of
a share for which a Right was exercisable immediately prior to the first
occurrence of a Section 11(a)(ii) Event by the Purchase Price in effect
immediately prior to such first occurrence), and dividing that product
(which, following the first occurrence of a Section 13 Event, shall be
referred to as the "Purchase Price" for each Right and for all purposes of
this Agreement) by (2) 50% of the current market price (determined pursuant
to Section 11(d)(i) hereof) per share of the Common Stock of such Principal
Party on the date of consummation of such Section 13 Event; (ii) such
Principal Party shall thereafter be liable for, and shall assume, by virtue
of such Section 13 Event, all the obligations and duties of the Company
pursuant to this Agreement; (iii) the term "Company" shall thereafter be
deemed to refer to such Principal Party, it being specifically intended that
the provisions of Section 11 hereof shall apply only to such Principal Party
following the first occurrence of a Section 13 Event; (iv) such Principal
Party shall take such steps (including, but not limited to, the reservation
of a sufficient number of shares of its Common Stock) in connection with the
consummation of any such transaction as may be necessary to assure that the
provisions hereof shall thereafter be applicable, as nearly as reasonably may
be, in relation to its shares of Common Stock thereafter deliverable upon the
exercise of the Rights; and (v) the provisions of Section 11(a)(ii) hereof
shall be of no effect following the first occurrence of any Section 13 Event.

                  (b) "Principal Party" shall mean

                        (i) in the case of any transaction described in clause
      (x) or (y) of the first sentence of Section 13(a), the Person that is the
      issuer of any securities into which shares of Class A Common Stock of the
      Company are converted in such merger or consolidation, and if no
      securities are so issued, the Person that is the other party to such
      merger or consolidation; and

                        (ii) in the case of any transaction described in clause
      (z) of the first sentence of Section 13(a), the Person that is the party
      receiving the greatest portion of the assets or earning power transferred
      pursuant to such transaction or transactions;

PROVIDED, however, that in any such case, (1) if the Common Stock of such Person
is not at such time and has not been continuously over the preceding twelve (12)
month period registered under Section 12 of the Exchange Act, and such Person is
a direct or indirect Subsidiary of another Person the Common Stock of which is
and has been so

                                       26
<Page>

registered, "Principal Party" shall refer to such other Person; and (2) in
case such Person is a Subsidiary, directly or indirectly, of more than one
Person, the Common Stocks of two or more of which are and have been so
registered, "Principal Party" shall refer to whichever of such Persons is the
issuer of the Common Stock having the greatest aggregate market value.

                  (c) The Company shall not consummate any Section 13 Event
unless the Principal Party shall have a sufficient number of authorized
shares of its Common Stock which have not been issued or reserved for
issuance to permit the exercise in full of the Rights in accordance with this
Section 13 and unless prior thereto the Company and such Principal Party
shall have executed and delivered to the Rights Agent a supplemental
agreement providing for the terms set forth in paragraphs (a) and (b) of this
Section 13 and further providing that, as soon as practicable after the date
of any such Section 13 Event, the Principal Party will

                        (i) prepare and file a registration statement under the
      Act, with respect to the Rights and the securities purchasable upon
      exercise of the Rights on an appropriate form, and will use its best
      efforts to cause such registration statement to (A) become effective as
      soon as practicable after such filing and (B) remain effective (with a
      prospectus at all times meeting the requirements of the Act) until the
      Expiration Date;

                        (ii) take all such other action as may be necessary to
      enable the Principal Party to issue the securities purchasable upon
      exercise of the Rights, including but not limited to the registration or
      qualification of such securities under all requisite securities laws of
      the jurisdictions of the various states and the listing of such securities
      on such exchanges and trading markets as may be necessary or appropriate;
      and

                        (iii) will deliver to holders of the Rights historical
      financial statements for the Principal Party and each of its Affiliates
      which comply in all respects with the requirements for registration on
      Form 10 under the Exchange Act.

The provisions of this Section 13 shall similarly apply to successive mergers or
consolidations or sales or other transfers. In the event that a Section 13 Event
shall occur at any time after the occurrence of a Section 11(a)(ii) Event, the
Rights which have not theretofore been exercised shall thereafter become
exercisable in the manner described in Section 13(a).

                                       27
<Page>

                  (d) Notwithstanding anything in this Agreement to the
contrary, Section 13 shall not be applicable to a transaction described in
subparagraphs (x) and (y) of Section 13(a) if (i) such transaction is
consummated with a Person or Persons who acquired shares of Common Stock
pursuant to a Qualifying Offer (or a wholly owned subsidiary of any such
Person or Persons), (ii) the price per share of Common Stock offered in such
transaction is not less than the price per share of Common Stock paid to all
holders of shares of Common Stock whose shares were purchased pursuant to
such tender offer or exchange offer and (iii) the form of consideration being
offered to the remaining holders of shares of Common Stock pursuant to such
transaction is the same as the form of consideration paid pursuant to such
tender offer or exchange offer. Upon consummation of any such transaction
contemplated by this Section 13(d), all Rights hereunder shall expire.

            SECTION 14. FRACTIONAL RIGHTS AND FRACTIONAL SHARES.

                  (a) The Company shall not be required to issue fractions of
Rights, except prior to the Distribution Date as provided in Section 11(p)
hereof, or to distribute Rights Certificates which evidence fractional
Rights. In lieu of such fractional Rights, there shall be paid to the
registered holders of the Rights Certificates, with regard to which such
fractional Rights would otherwise be issuable, an amount in cash equal to the
same fraction of the current market value of a whole Right. For purposes of
this Section 14(a), the current market value of a whole Right shall be the
closing price of the Rights for the Trading Day immediately prior to the date
on which such fractional Rights would have been otherwise issuable. The
closing price of the Rights for any day shall be the last sale price, regular
way, or, in case no such sale takes place on such day, the average of the
closing bid and asked prices, regular way, in either case as reported in the
principal consolidated transaction reporting system with respect to
securities listed or admitted to trading on the New York Stock Exchange or,
if the Rights are not listed or admitted to trading on the New York Stock
Exchange, as reported in the principal consolidated transaction reporting
system with respect to securities listed on the principal national securities
exchange on which the Rights are listed or admitted to trading, or if the
Rights are not listed or admitted to trading on any national securities
exchange, the last quoted price or, if not so quoted, the average of the high
bid and low asked prices in the over-the-counter market, as reported by
NASDAQ or such other system then in use or, if on any such date the Rights
are not quoted by any such organization, the average of the closing bid and
asked prices as furnished by a professional market maker making a market in
the Rights selected by the Board of Directors of the Company. If on any such
date no such market maker is making a market in the Rights the fair value of
the Rights on such date as determined in good faith by the Board of Directors
of the Company shall be used.

                                       28
<Page>

                  (b) The Company shall not be required to issue fractions of
shares of Preferred Stock (other than fractions which are integral multiples
of one one-thousandth of a share of Preferred Stock) upon exercise of the
Rights or to distribute certificates which evidence fractional shares of
Preferred Stock (other than fractions which are integral multiples of one
one-thousandth of a share of Preferred Stock). In lieu of fractional shares
of Preferred Stock that are not integral multiples of one one-thousandth of a
share of Preferred Stock, the Company may pay to the registered holders of
Rights Certificates at the time such Rights are exercised as herein provided
an amount in cash equal to the same fraction of the current market value of
one one-thousandth of a share of Preferred Stock. For purposes of this
Section 14(b), the current market value of one one-thousandth of a share of
Preferred Stock shall be one one-thousandth of the closing price of a share
of Preferred Stock (as determined pursuant to Section 11(d)(ii) hereof) for
the Trading Day immediately prior to the date of such exercise.

                  (c) Following the occurrence of a Triggering Event, the
Company shall not be required to issue fractions of shares of Class A Common
Stock upon exercise of the Rights or to distribute certificates which
evidence fractional shares of Class A Common Stock. In lieu of fractional
shares of Class A Common Stock, the Company may pay to the registered holders
of Rights Certificates at the time such Rights are exercised as herein
provided an amount in cash equal to the same fraction of the current market
value of one (1) share of Class A Common Stock. For purposes of this Section
14(c), the current market value of one share of Class A Common Stock shall be
the closing price of one share of Class A Common Stock (as determined
pursuant to Section 11(d)(i) hereof) for the Trading Day immediately prior to
the date of such exercise.

                  (d) The holder of a Right by the acceptance of the Rights
expressly waives his or her right to receive any fractional Rights or any
fractional shares upon exercise of a Right, except as permitted by this
Section 14.

            Section 15. RIGHTS OF ACTION. All rights of action in respect of
this Agreement are vested in the respective registered holders of the Rights
Certificates (and, prior to the Distribution Date, the registered holders of
the Common Stock); and any registered holder of any Rights Certificate (or,
prior to the Distribution Date, of the Common Stock), without the consent of
the Rights Agent or of the holder of any other Rights Certificate (or, prior
to the Distribution Date, of the Common Stock), may, in his or her own behalf
and for his or her own benefit, enforce, and may institute and maintain any
suit, action or proceeding against the Company to enforce, or otherwise act
in respect of, his or her right to exercise the Rights evidenced by such
Rights Certificate in the manner provided in such Rights Certificate and in
this Agreement. Without limiting the foregoing or any remedies available to
the holders

                                       29
<Page>

of Rights, it is specifically acknowledged that the holders of Rights would
not have an adequate remedy at law for any breach of this Agreement and shall
be entitled to specific performance of the obligations hereunder and
injunctive relief against actual or threatened violations of the obligations
hereunder of any Person subject to this Agreement.

            Section 16. AGREEMENT OF RIGHTS HOLDERS. Every holder of a Right
by accepting the same consents and agrees with the Company and the Rights
Agent and with every other holder of a Right that:

                  (a) prior to the Distribution Date, the Rights will be
transferable only in connection with the transfer of Common Stock;

                  (b) after the Distribution Date, the Rights Certificates
are transferable only on the registry books of the Rights Agent if
surrendered at the principal office or offices of the Rights Agent designated
for such purposes, duly endorsed or accompanied by a proper instrument of
transfer and with the appropriate forms and certificates fully executed;

                  (c) subject to Section 6(a) and Section 7(f) hereof, the
Company and the Rights Agent may deem and treat the Person in whose name a
Rights Certificate (or, prior to the Distribution Date, the associated Common
Stock certificate) is registered as the absolute owner thereof and of the
Rights evidenced thereby (notwithstanding any notations of ownership or
writing on the Rights Certificates or the associated Common Stock certificate
made by anyone other than the Company or the Rights Agent) for all purposes
whatsoever, and neither the Company nor the Rights Agent, subject to the last
sentence of Section 7(e) hereof, shall be required to be affected by any
notice to the contrary; and

                  (d) notwithstanding anything in this Agreement to the
contrary, neither the Company nor the Rights Agent shall have any liability
to any holder of a Right or other Person as a result of its inability to
perform any of its obligations under this Agreement by reason of any
preliminary or permanent injunction or other order, decree or ruling issued
by a court of competent jurisdiction or by a governmental, regulatory or
administrative agency or commission, or any statute, rule, regulation or
executive order promulgated or enacted by any governmental authority,
prohibiting or otherwise restraining performance of such obligation;
PROVIDED, however, the Company must use its best efforts to have any such
order, decree or ruling lifted or otherwise overturned as soon as possible.

            Section 17. RIGHTS CERTIFICATE HOLDER NOT DEEMED A SHAREHOLDER.
No holder, as such, of any Rights Certificate shall be entitled to vote,
receive dividends or be deemed for any purpose the holder of the number of
one one-thousandths of a

                                       30
<Page>

share of Preferred Stock or any other securities of the Company which may at
any time be issuable on the exercise of the Rights represented thereby, nor
shall anything contained herein or in any Rights Certificate be construed to
confer upon the holder of any Rights Certificate, as such, any of the rights
of a shareholder of the Company or any right to vote for the election of
directors or upon any matter submitted to shareholders at any meeting
thereof, or to give or withhold consent to any corporate action, or to
receive notice of meetings or other actions affecting shareholders (except as
provided in Section 25 hereof), or to receive dividends or subscription
rights, or otherwise, until the Right or Rights evidenced by such Rights
Certificate shall have been exercised in accordance with the provisions
hereof.

            SECTION 18. CONCERNING THE RIGHTS AGENT.

                  (a) The Company agrees to pay to the Rights Agent
reasonable compensation for all services rendered by it hereunder and, from
time to time, on demand of the Rights Agent, its reasonable expenses and
counsel fees and disbursements and other disbursements incurred in the
administration and execution of this Agreement and the exercise and
performance of its duties hereunder. The Company also agrees to indemnify the
Rights Agent for, and to hold it harmless against, any loss, liability, or
expense, incurred without negligence, bad faith or willful misconduct on the
part of the Rights Agent, for anything done or omitted by the Rights Agent in
connection with the acceptance and administration of this Agreement,
including the costs and expenses of defending against any claim of liability
in the premises.

                  (b) The Rights Agent shall be protected and shall incur no
liability for or in respect of any action taken, suffered or omitted by it in
connection with its administration of this Agreement in reliance upon any
Rights Certificate or certificate for Common Stock or for other securities of
the Company, instrument of assignment or transfer, power of attorney,
endorsement, affidavit, letter, notice, direction, consent, certificate,
statement, or other paper or document believed by it to be genuine and to be
signed, executed and, where necessary, verified or acknowledged, by the
proper Person or Persons.

            Section 19. MERGER OR CONSOLIDATION OR CHANGE OF NAME OF RIGHTS
AGENT.

                  (a) Any corporation into which the Rights Agent or any
successor Rights Agent may be merged or with which it may be consolidated, or
any corporation resulting from any merger or consolidation to which the
Rights Agent or any successor Rights Agent shall be a party, or any
corporation succeeding to the corporate trust or shareholder services
business of the Rights Agent or any successor

                                       31
<Page>

Rights Agent, shall be the successor to the Rights Agent under this Agreement
without the execution or filing of any paper or any further act on the part
of any of the parties hereto; PROVIDED, however, that such corporation would
be eligible for appointment as a successor Rights Agent under the provisions
of Section 21 hereof. In case at the time such successor Rights Agent shall
succeed to the agency created by this Agreement, any of the Rights
Certificates shall have been countersigned but not delivered, any such
successor Rights Agent may adopt the countersignature of a predecessor Rights
Agent and deliver such Rights Certificates so countersigned; and in case at
that time any of the Rights Certificates shall not have been countersigned,
any successor Rights Agent may countersign such Rights Certificates either in
the name of the predecessor or in the name of the successor Rights Agent; and
in all such cases such Rights Certificates shall have the full force provided
in the Rights Certificates and in this Agreement.

                  (b) In case at any time the name of the Rights Agent shall
be changed and at such time any of the Rights Certificates shall have been
countersigned but not delivered, the Rights Agent may adopt the
countersignature under its prior name and deliver Rights Certificates so
countersigned; and in case at that time any of the Rights Certificates shall
not have been countersigned, the Rights Agent may countersign such Rights
Certificates either in its prior name or in its changed name; and in all such
cases such Rights Certificates shall have the full force provided in the
Rights Certificates and in this Agreement.

            Section 20. DUTIES OF RIGHTS AGENT. The Rights Agent undertakes
the duties and obligations imposed by this Agreement upon the following terms
and conditions, by all of which the Company and the holders of Rights
Certificates, by their acceptance thereof, shall be bound:

                  (a) The Rights Agent may consult with legal counsel (who
may be legal counsel for the Company), and the opinion of such counsel shall
be full and complete authorization and protection to the Rights Agent as to
any action taken or omitted by it in good faith and in accordance with such
opinion.

                  (b) Whenever in the performance of its duties under this
Agreement the Rights Agent shall deem it necessary or desirable that any fact
or matter (including, without limitation, the identity of any Acquiring
Person and the determination of "Current Market Price") be proved or
established by the Company prior to taking or suffering any action hereunder,
such fact or matter (unless other evidence in respect thereof be herein
specifically prescribed) may be deemed to be conclusively proved and
established by a certificate signed by the Chairman of the Board, the
President, any Managing Director, the Treasurer, any Assistant Treasurer, the
Secretary or any Assistant Secretary of the Company and delivered to the
Rights

                                       32
<Page>

Agent; and such certificate shall be full authorization to the Rights Agent
for any action taken or suffered in good faith by it under the provisions of
this Agreement in reliance upon such certificate.

                  (c) The Rights Agent shall be liable hereunder only for its
own negligence, bad faith or willful misconduct.

                  (d) The Rights Agent shall not be liable for or by reason
of any of the statements of fact or recitals contained in this Agreement or
in the Rights Certificates or be required to verify the same (except as to
its countersignature on such Rights Certificates), but all such statements
and recitals are and shall be deemed to have been made by the Company only.

                  (e) The Rights Agent shall not be under any responsibility
in respect of the validity of this Agreement or the execution and delivery
hereof (except the due execution hereof by the Rights Agent) or in respect of
the validity or execution of any Rights Certificate (except its
countersignature thereof); nor shall it be responsible for any breach by the
Company of any covenant or condition contained in this Agreement or in any
Rights Certificate; nor shall it be responsible for any adjustment required
under the provisions of Section 11, Section 13, or Section 24 hereof or
responsible for the manner, method or amount of any such adjustment or the
ascertaining of the existence of facts that would require any such adjustment
(except with respect to the exercise of Rights evidenced by Rights
Certificates after actual notice of any such adjustment); nor shall it by any
act hereunder be deemed to make any representation or warranty as to the
authorization or reservation of any shares of Common Stock or Preferred Stock
to be issued pursuant to this Agreement or any Rights Certificate or as to
whether any shares of Common Stock or Preferred Stock will, when so issued,
be validly authorized and issued, fully paid and nonassessable.

                  (f) The Company agrees that it will perform, execute,
acknowledge and deliver or cause to be performed, executed, acknowledged and
delivered all such further and other acts, instruments and assurances as may
reasonably be required by the Rights Agent for the carrying out or performing
by the Rights Agent of the provisions of this Agreement.

                  (g) The Rights Agent is hereby authorized and directed to
accept instructions with respect to the performance of its duties hereunder
from the Chairman of the Board, the President, any Managing Director, the
Secretary, any Assistant Secretary, the Treasurer or any Assistant Treasurer
of the Company, and to apply to such officers for advice or instructions in
connection with its duties, and it

                                       33
<Page>

shall not be liable for any action taken or suffered to be taken by it in
good faith in accordance with instructions of any such officer.

                  (h) The Rights Agent and any shareholder, director, officer
or employee of the Rights Agent may buy, sell or deal in any of the Rights or
other securities of the Company or become pecuniarily interested in any
transaction in which the Company may be interested, or contract with or lend
money to the Company or otherwise act as fully and freely as though it were
not Rights Agent under this Agreement. Nothing herein shall preclude the
Rights Agent from acting in any other capacity for the Company or for any
other legal entity.

                  (i) The Rights Agent may execute and exercise any of the
rights or powers hereby vested in it or perform any duty hereunder either
itself or by or through its attorneys or agents, and the Rights Agent shall
not be answerable or accountable for any act, default, neglect or misconduct
of any such attorneys or agents or for any loss to the Company resulting from
any such act, default, neglect or misconduct; PROVIDED, however, reasonable
care was exercised in the selection and continued employment thereof.

                  (j) No provision of this Agreement shall require the Rights
Agent to expend or risk its own funds or otherwise incur any financial
liability in the performance of any of its duties hereunder or in the
exercise of its rights if there shall be reasonable grounds for believing
that repayment of such funds or adequate indemnification against such risk or
liability is not reasonably assured to it.

                  (k) If, with respect to any Right Certificate surrendered
to the Rights Agent for exercise or transfer, the certificate attached to the
form of assignment or form of election to purchase, as the case may be, has
either not been completed or indicates an affirmative response to clause 1
and/or 2 thereof, the Rights Agent shall not take any further action with
respect to such requested exercise of transfer without first consulting with
the Company.

            Section 21. CHANGE OF RIGHTS AGENT. The Rights Agent or any
successor Rights Agent may resign and be discharged from its duties under
this Agreement upon thirty (30) days' notice in writing mailed to the
Company, and to each transfer agent of the Common Stock and Preferred Stock,
by registered or certified mail, and to the holders of the Rights
Certificates by first-class mail. The Company may remove the Rights Agent or
any successor Rights Agent upon thirty (30) days' notice in writing, mailed
to the Rights Agent or successor Rights Agent, as the case may be, and to
each transfer agent of the Common Stock and Preferred Stock, by registered or
certified mail, and to the holders of the Rights Certificates by first-class
mail. If the Rights Agent shall resign or be removed or shall otherwise

                                       34
<Page>

become incapable of acting, the Company shall appoint a successor to the
Rights Agent. If the Company shall fail to make such appointment within a
period of thirty (30) days after giving notice of such removal or after it
has been notified in writing of such resignation or incapacity by the
resigning or incapacitated Rights Agent or by the holder of a Rights
Certificate (who shall, with such notice, submit his Rights Certificate for
inspection by the Company), then any registered holder of any Rights
Certificate may apply to any court of competent jurisdiction for the
appointment of a new Rights Agent. Any successor Rights Agent, whether
appointed by the Company or by such a court, shall be a corporation, trust
company, limited liability company or limited partnership (or similar form of
entity) authorized to conduct business under the laws of the United States or
any state of the United States, in good standing, having a principal office
in any state of the United States, which is authorized under such laws to
exercise corporate trust, fiduciary or shareholder services powers and is
subject to supervision or examination by federal or state authority. After
appointment, the successor Rights Agent shall be vested with the same powers,
rights, duties and responsibilities as if it had been originally named as
Rights Agent without further act or deed; but the predecessor Rights Agent
shall deliver and transfer to the successor Rights Agent any property at the
time held by it hereunder, and execute and deliver any further assurance,
conveyance, act or deed necessary for the purpose. Not later than the
effective date of any such appointment, the Company shall file notice thereof
in writing with the predecessor Rights Agent and each transfer agent of the
Common Stock and the Preferred Stock, and mail a notice thereof in writing to
the registered holders of the Rights Certificates. Failure to give any notice
provided for in this Section 21, however, or any defect therein, shall not
affect the legality or validity of the resignation or removal of the Rights
Agent or the appointment of the successor Rights Agent, as the case may be.

            Section 22. ISSUANCE OF NEW RIGHTS CERTIFICATES. Notwithstanding
any of the provisions of this Agreement or of the Rights to the contrary, the
Company may, at its option, issue new Rights Certificates evidencing Rights
in such form as may be approved by its Board of Directors to reflect any
adjustment or change in the Purchase Price and the number or kind or class of
shares or other securities or property purchasable under the Rights
Certificates made in accordance with the provisions of this Agreement. In
addition, in connection with the issuance or sale of shares of Common Stock
following the Distribution Date and prior to the redemption or expiration of
the Rights, the Company (a) shall, with respect to shares of Common Stock so
issued or sold pursuant to the exercise of stock options or under any
employee plan or arrangement, granted or awarded as of the Distribution Date,
or upon the exercise, conversion or exchange of securities hereinafter issued
by the Company, and (b) may, in any other case, if deemed necessary or
appropriate by the Board of Directors of the Company, issue Rights
Certificates representing the appropriate number of Rights in connection with
such issuance or sale; provided,

                                       35
<Page>

however, that (i) no such Rights Certificate shall be issued if, and to the
extent that, the Company shall be advised by counsel that such issuance would
create a significant risk of material adverse tax consequences to the Company
or the Person to whom such Rights Certificate would be issued, and (ii) no
such Rights Certificate shall be issued if, and to the extent that,
appropriate adjustment shall otherwise have been made in lieu of the issuance
thereof.

            SECTION 23. REDEMPTION AND TERMINATION.

                  (a) The Board of Directors of the Company may, at its
option, at any time prior to the earlier of (i) the Close of Business on the
tenth day following the Stock Acquisition Date (or, if the Stock Acquisition
Date shall have occurred prior to the Effective Date, the Close of Business
on the tenth day following the Effective Date), or (ii) the Final Expiration
Date, redeem all but not less than all the then outstanding Rights at a
redemption price of $.01 per Right, as such amount may be appropriately
adjusted to reflect any stock split, stock dividend or similar transaction
occurring after the date hereof (such redemption price being hereinafter
referred to as the "Redemption Price"). Notwithstanding anything contained in
this Agreement to the contrary, the Rights shall not be exercisable after the
first occurrence of a Section 11(a)(ii) Event until such time as the
Company's right of redemption hereunder has expired. The Company may, at its
option, pay the Redemption Price in cash, shares of Class A Common Stock
(based on the "current market price", as defined in Section 11(d)(i) hereof,
of the Class A Common Stock at the time of redemption) or any other form of
consideration deemed appropriate by the Board of Directors.

                  (b) Immediately upon the action of the Board of Directors
of the Company ordering the redemption of the Rights, evidence of which shall
have been filed with the Rights Agent and without any further action and
without any notice, the right to exercise the Rights will terminate and the
only right thereafter of the holders of Rights shall be to receive the
Redemption Price for each Right so held. Promptly after the action of the
Board of Directors ordering the redemption of the Rights, the Company shall
give notice of such redemption to the Rights Agent and the holders of the
then outstanding Rights by mailing such notice to all such holders at each
holder's last address as it appears upon the registry books of the Rights
Agent or, prior to the Distribution Date, on the registry books of the
transfer agent for the Common Stock. Any notice which is mailed in the manner
herein provided shall be deemed given, whether or not the holder receives the
notice. Each such notice of redemption will state the method by which the
payment of the Redemption Price will be made.

                                       36
<Page>

            SECTION 24. EXCHANGE.

                  (a) The Board of Directors of the Company may, at its
option, at any time after any Person becomes an Acquiring Person, exchange
all or part of the then outstanding and exercisable Rights (which shall not
include Rights that have become void pursuant to the provisions of Section
7(e) hereof) for shares of Class A Common Stock at an exchange ratio of one
share of Class A Common Stock per Right, appropriately adjusted to reflect
any stock split, stock dividend or similar transaction occurring after the
date hereof (such exchange ratio being hereinafter referred to as the
"Exchange Ratio"); PROVIDED, HOWEVER, that no such exchange of the Rights may
be authorized by the Board of Directors at any time after any Person (other
than the Company, any Subsidiary of the Company, any employee benefit plan of
the Company or any such Subsidiary, or any entity holding Class A Common
Stock for or pursuant to the terms of any such plan), together with all
Affiliates and Associates of such Person, becomes the Beneficial Owner of 50%
or more of the Common Stock then outstanding.

                  (b) Immediately upon the action of the Board of Directors
of the Company ordering the exchange of any Rights pursuant to subsection (a)
of this Section 24 and without any further action and without any notice, the
right to exercise such Rights shall terminate and the only right thereafter
of a holder of such Rights shall be to receive that number of shares of Class
A Common Stock equal to the number of such Rights held by such holder
multiplied by the Exchange Ratio. The Company shall promptly give public
notice of any such exchange; PROVIDED, HOWEVER, that the failure to give, or
any defect in, such notice shall not affect the validity of such exchange.
The Company promptly shall mail a notice of any such exchange to all of the
holders of such Rights at their last addresses as they appear upon the
registry books of the Rights Agent. Any notice which is mailed in the manner
herein provided shall be deemed given, whether or not the holder receives the
notice. Each such notice of exchange will state the method by which the
exchange of the Class A Common Stock for Rights will be effected and, in the
event of any partial exchange, the number of Rights which will be exchanged.
Any partial exchange shall be effected pro rata based on the number of Rights
(other than Rights which have become void pursuant to the provisions of
Section 7(e) hereof) held by each holder of Rights.

                  (c) In any exchange pursuant to this Section 24, the
Company, at its option, may substitute shares of Preferred Stock (or
equivalent preferred stock, as such term is defined in paragraph (b) of
Section 11 hereof) for shares of Class A Common Stock exchangeable for
Rights, at the initial rate of one one-hundredth of a share of Preferred
Stock (or equivalent preferred stock) for each

                                       37
<Page>

share of Class A Common Stock, as appropriately adjusted to reflect stock
splits, stock dividends and other similar transactions after the date hereof.

                  (d) In the event that there shall not be sufficient shares
of Class A Common Stock issued but not outstanding or authorized but unissued
to permit any exchange of Rights as contemplated in accordance with this
Section 24, the Company shall take all such action as may be necessary to
authorize additional shares of Class A Common Stock for issuance upon
exchange of the Rights.

                  (e) The Company shall not be required to issue fractions of
shares of Class A Common Stock or to distribute certificates which evidence
fractional shares of Class A Common Stock. In lieu of such fractional shares
of Class A Common Stock, there shall be paid to the registered holders of the
Right Certificates with regard to which such fractional share of Class A
Common Stock would otherwise be issuable, an amount in cash equal to the same
fraction of the Current Market Value of a whole share of Class A Common
Stock. For the purposes of this subsection (e), the "Current Market Value" of
a whole share of Class A Common Stock shall be the closing price of a share
of Class A Common Stock (as determined pursuant to the second sentence of
Section 11(d)(i) hereof) for the Trading Day immediately prior to the date of
exchange pursuant to this Section 24.

            SECTION 25. NOTICE OF CERTAIN EVENTS.

                  (a) In case the Company shall propose, at any time after
the Distribution Date, (i) to pay any dividend payable in stock of any class
to the holders of Preferred Stock or to make any other distribution to the
holders of Preferred Stock (other than a regular periodic cash dividend out
of earnings or retained earnings of the Company), or (ii) to offer to the
holders of Preferred Stock rights or warrants to subscribe for or to purchase
any additional shares of Preferred Stock or shares of stock of any class or
any other securities, rights or options, or (iii) to effect any
reclassification of its Preferred Stock (other than a reclassification
involving only the subdivision of outstanding shares of Preferred Stock), or
(iv) to effect any consolidation or merger into or with any other Person
(other than a Subsidiary of the Company in a transaction which complies with
Section 11(o) hereof), or to effect any sale or other transfer (or to permit
one or more of its Subsidiaries to effect any sale or other transfer), in one
transaction or a series of related transactions, of more than 50% of the
assets or earning power of the Company and its Subsidiaries (taken as a
whole) to any other Person or Persons (other than the Company and/or any of
its Subsidiaries in one or more transactions each of which complies with
Section 11(o) hereof), or (v) to effect the liquidation, dissolution or
winding up of the Company, then, in each such case, the Company shall give to
each holder of a Rights Certificate, to the extent feasible and in accordance
with Section 26 hereof, a notice of such proposed action,

                                       38
<Page>

which shall specify the record date for the purposes of such stock dividend,
distribution of rights or warrants, or the date on which such
reclassification, consolidation, merger, sale, transfer, liquidation,
dissolution, or winding up is to take place and the date of participation
therein by the holders of the shares of Preferred Stock, if any such date is
to be fixed, and such notice shall be so given in the case of any action
covered by clause (i) or (ii) above at least twenty (20) days prior to the
record date for determining holders of the shares of Preferred Stock for
purposes of such action, and in the case of any such other action, at least
twenty (20) days prior to the date of the taking of such proposed action or
the date of participation therein by the holders of the shares of Preferred
Stock whichever shall be the earlier.

                  (b) In case any of the events set forth in Section
11(a)(ii) hereof shall occur, then, in any such case, (i) the Company shall
as soon as practicable thereafter give to each holder of a Rights
Certificate, to the extent feasible and in accordance with Section 26 hereof,
a notice of the occurrence of such event, which shall specify the event and
the consequences of the event to holders of Rights under Section 11(a)(ii)
hereof, and (ii) all references in the preceding paragraph to Preferred Stock
shall be deemed thereafter to refer to Common Stock and/or, if appropriate,
other securities.

            Section 26. NOTICES. Notices or demands authorized by this
Agreement to be given or made by the Rights Agent or by the holder of any
Rights Certificate to or on the Company shall be sufficiently given or made
if sent by first-class mail, postage prepaid, addressed (until another
address is filed in writing with the Rights Agent) as follows:

                  Chicago Mercantile Exchange Holdings Inc.
                  30 South Wacker Drive
                  Chicago, Illinois  60606
                  Attention:  General Counsel

Subject to the provisions of Section 21, any notice or demand authorized by
this Agreement to be given or made by the Company or by the holder of any
Rights Certificate to or on the Rights Agent shall be sufficiently given or
made if sent by first-class mail, postage prepaid, addressed (until another
address is filed in writing with the Company) as follows:

                  Mellon Investor Services LLC
                  150 North Wacker Drive, Suite 2120
                  Chicago, IL 60606
                  Attention: Relationship Manager

                                       39
<Page>

            with a copy to:

                  Mellon Investor Services LLC
                  85 Challenger Road
                  Ridgefield Park, NJ 07660
                  Attention: General Counsel

Notices or demands authorized by this Agreement to be given or made by the
Company or the Rights Agent to the holder of any Rights Certificate (or, if
prior to the Distribution Date, to the holder of certificates representing
shares of Common Stock) shall be sufficiently given or made if sent by
first-class mail, postage prepaid, addressed to such holder at the address of
such holder as shown on the registry books of the Company.

            Section 27. SUPPLEMENTS AND AMENDMENTS. Prior to the Distribution
Date, the Company and the Rights Agent shall, if the Company so directs,
supplement or amend any provision of this Agreement without the approval of
any holders of certificates representing shares of Common Stock. From and
after the Distribution Date, the Company and the Rights Agent shall, if the
Company so directs, supplement or amend this Agreement without the approval
of any holders of Rights Certificates in order (i) to cure any ambiguity,
(ii) to correct or supplement any provision contained herein which may be
defective or inconsistent with any other provisions herein, (iii) to shorten
or lengthen any time period hereunder, or (iv) to change or supplement the
provisions hereunder in any manner which the Company may deem necessary or
desirable and which shall not adversely affect the interests of the holders
of Rights Certificates (other than an Acquiring Person or an Affiliate or
Associate of an Acquiring Person); provided, this Agreement may not be
supplemented or amended to lengthen, pursuant to clause (iii) of this
sentence, (A) a time period relating to when the Rights may be redeemed at
such time as the Rights are not then redeemable, or (B) any other time period
unless such lengthening is for the purpose of protecting, enhancing or
clarifying the rights of, and/or the benefits to, the holders of Rights. Upon
the delivery of a certificate from an appropriate officer of the Company
which states that the proposed supplement or amendment is in compliance with
the terms of this Section 27, the Rights Agent shall execute such supplement
or amendment. Prior to the Distribution Date, the interests of the holders of
Rights shall be deemed coincident with the interests of the holders of Common
Stock.

                                        40
<Page>

            Section 28. SUCCESSORS. All the covenants and provisions of this
Agreement by or for the benefit of the Company or the Rights Agent shall bind
and inure to the benefit of their respective successors and assigns hereunder.

            Section 29. DETERMINATIONS AND ACTIONS BY THE BOARD OF DIRECTORS,
ETC. For all purposes of this Agreement, any calculation of the number of
shares of Common Stock outstanding at any particular time, including for
purposes of determining the particular percentage of such outstanding shares
of Common Stock of which any Person is the Beneficial Owner, shall be made in
accordance with the last sentence of Rule 13d-3(d)(1)(i) of the General Rules
and Regulations under the Exchange Act. The Board of Directors of the Company
shall have the exclusive power and authority to administer this Agreement and
to exercise all rights and powers specifically granted to the Board or to the
Company, or as may be necessary or advisable in the administration of this
Agreement, including, without limitation, the right and power to (i)
interpret the provisions of this Agreement, and (ii) make all determinations
deemed necessary or advisable for the administration of this Agreement
(including a determination to redeem or not redeem the Rights or to amend the
Agreement). All such actions, calculations, interpretations and
determinations (including, for purposes of clause (y) below, all omissions
with respect to the foregoing) which are done or made by the Board in good
faith, shall (x) be final, conclusive and binding on the Company, the Rights
Agent, the holders of the Rights and all other parties, and (y) not subject
the Board to any liability to the holders of the Rights.

            Section 30. BENEFITS OF THIS AGREEMENT. Nothing in this Agreement
shall be construed to give to any Person other than the Company, the Rights
Agent and the registered holders of the Rights Certificates (and, prior to
the Distribution Date, registered holders of the Common Stock) any legal or
equitable right, remedy or claim under this Agreement; but this Agreement
shall be for the sole and exclusive benefit of the Company, the Rights Agent
and the registered holders of the Rights Certificates (and, prior to the
Distribution Date, registered holders of the Common Stock).

            Section 31. SEVERABILITY. If any term, provision, covenant or
restriction of this Agreement is held by a court of competent jurisdiction or
other authority to be invalid, void or unenforceable, the remainder of the
terms, provisions, covenants and restrictions of this Agreement shall remain
in full force and effect and shall in no way be affected, impaired or
invalidated; provided, however, that notwithstanding anything in this
Agreement to the contrary, if any such term, provision, covenant or
restriction is held by such court or authority to be invalid, void or
unenforceable and the Board of Directors of the Company determines in its
good faith judgment that severing the invalid language from this Agreement
would

                                       41
<Page>

adversely affect the purpose or effect of this Agreement, the right of
redemption set forth in Section 23 hereof shall be reinstated and shall not
expire until the Close of Business on the tenth day following the date of
such determination by the Board of Directors.

            Section 32. GOVERNING LAW. This Agreement, each Right and each
Rights Certificate issued hereunder shall be deemed to be a contract made
under the laws of the State of Delaware and for all purposes shall be
governed by and construed in accordance with the laws of such State
applicable to contracts made and to be performed entirely within such State.

            Section 33. COUNTERPARTS. This Agreement may be executed in any
number of counterparts and each of such counterparts shall for all purposes
be deemed to be an original, and all such counterparts shall together
constitute but one and the same instrument.

            Section 34. DESCRIPTIVE HEADINGS. Descriptive headings of the
several Sections of this Agreement are inserted for convenience only and
shall not control or affect the meaning or construction of any of the
provisions hereof.

                                       42
<Page>

            IN WITNESS WHEREOF, the parties hereto have caused this Agreement to
be duly executed and their respective corporate seals to be hereunto affixed and
attested, all as of the day and year first above written.

Attest:                              CHICAGO MERCANTILE EXCHANGE
                                     HOLDINGS INC.

By                                   By
   --------------------------           ---------------------------
      Name:                                Name:
      Title:                               Title:

Attest:                              MELLON INVESTOR SERVICES LLC

By                                   By
   --------------------------           ---------------------------
      Name:                                Name:
      Title:                               Title:

                                       43
<Page>

                                                                       EXHIBIT A

                                     FORM OF
                   CERTIFICATE OF DESIGNATION, PREFERENCES
                          AND RIGHTS OF SERIES A JUNIOR
                          PARTICIPATING PREFERRED STOCK

                                       of

                           CHICAGO MERCANTILE EXCHANGE
                                HOLDINGS INC.

            Pursuant to Section 151 of the General Corporation Law
                            of the State of Delaware

            The undersigned officers of Chicago Mercantile Exchange Holdings
Inc., a corporation organized and existing under the General Corporation Law
of the State of Delaware, in accordance with the provisions of Section 103
thereof, DO HEREBY CERTIFY:

            That pursuant to the authority conferred upon the Board of
Directors by the Amended and Restated Certificate of Incorporation of the
said Corporation, the said Board of Directors on ____________, 2001 adopted
the following resolution creating a series of 140,000 shares of Preferred
Stock designated as Series A Junior Participating Preferred Stock:

            RESOLVED, that pursuant to the authority vested in the Board of
Directors of this Corporation in accordance with the provisions of its
Amended and Restated Certificate of Incorporation, a series of Preferred
Stock of the Corporation be and it hereby is created, and that the
designation and amount thereof and the voting powers, preferences and
relative, participating, optional and other special rights of the shares of
such series, and the qualifications, limitations or restrictions thereof are
as follows:

            SECTION 1.  DESIGNATION AND AMOUNT.

            The shares of such series shall be designated as "Series A Junior
Participating Preferred Stock" and the number of shares constituting such
series shall be 140,000.

                                     A-1
<Page>

            SECTION 2.  DIVIDENDS AND DISTRIBUTIONS.

                  (a) The holders of shares of Series A Junior Participating
Preferred Stock shall be entitled to receive, when, as and if declared by the
Board of Directors out of funds legally available for the purpose, quarterly
dividends payable in cash on the last day of March, June, September and
December in each year (each such date being referred to herein as a
"Quarterly Dividend Payment Date"), commencing on the first Quarterly
Dividend Payment Date after the first issuance of a share or fraction of a
share of Series A Junior Participating Preferred Stock, in an amount per
share (rounded to the nearest cent) equal to the greater of (a) $.01 or (b)
subject to the provision for adjustment hereinafter set forth, 1,000 times
the aggregate per share amount of all cash dividends, and 1,000 times the
aggregate per share amount (payable in kind) of all non-cash dividends or
other distributions other than a dividend payable in shares of Class A Common
Stock or a subdivision of the outstanding shares of Common Stock (by
reclassification or otherwise), declared on the Class A Common Stock, par
value $.01 per share, of the Corporation (the "Class A Common Stock") since
the immediately preceding Quarterly Dividend Payment Date, or, with respect
to the first Quarterly Dividend Payment Date, since the first issuance of any
share or fraction of a share of Series A Junior Participating Preferred
Stock. In the event the Corporation shall at any time after the date of
consummation of the merger of CME Merger Subsidiary Inc. with and into
Chicago Mercantile Exchange Inc. (the "Rights Declaration Date") (i) declare
any dividend on Class A Common Stock payable in shares of Class A Common
Stock, (ii) subdivide the outstanding Class A Common Stock, or (iii) combine
the outstanding Common Stock into a smaller number of shares, then in each
such case the amount to which holders of shares of Series A Junior
Participating Preferred Stock were entitled immediately prior to such event
under clause (b) of the preceding sentence shall be adjusted by multiplying
such amount by a fraction the numerator of which is the number of shares of
Class A Common Stock outstanding immediately after such event and the
denominator of which is the number of shares of Class A Common Stock that
were outstanding immediately prior to such event.

                  (b) The Corporation shall declare a dividend or
distribution on the Series A Junior Participating Preferred Stock as provided
in Paragraph (a) above immediately after it declares a dividend or
distribution on the Class A Common Stock (other than a dividend payable in
shares of Class A Common Stock); provided that, in the event no dividend or
distribution shall have been declared on the Common Stock during the period
between any Quarterly Dividend Payment Date and the next subsequent Quarterly
Dividend Payment Date, a dividend of $.01 per share on the Series A Junior
Participating Preferred Stock shall nevertheless be payable on such
subsequent Quarterly Dividend Payment Date.

                                     A-2
<Page>

                  (c) Dividends shall begin to accrue and be cumulative on
outstanding shares of Series A Junior Participating Preferred Stock from the
Quarterly Dividend Payment Date next preceding the date of issue of such
shares of Series A Junior Participating Preferred Stock, unless the date of
issue of such shares is prior to the record date for the first Quarterly
Dividend Payment Date, in which case dividends on such shares shall begin to
accrue from the date of issue of such shares, or unless the date of issue is
a Quarterly Dividend Payment Date or is a date after the record date for the
determination of holders of shares of Series A Junior Participating Preferred
Stock entitled to receive a quarterly dividend and before such Quarterly
Dividend Payment Date, in either of which events such dividends shall begin
to accrue and be cumulative from such Quarterly Dividend Payment Date.
Accrued but unpaid dividends shall not bear interest. Dividends paid on the
shares of Series A Junior Participating Preferred Stock in an amount less
than the total amount of such dividends at the time accrued and payable on
such shares shall be allocated pro rata on a share-by-share basis among all
such shares at the time outstanding. The Board of Directors may fix a record
date for the determination of holders of shares of Series A Junior
Participating Preferred Stock entitled to receive payment of a dividend or
distribution declared thereon, which record date shall be no more than 30
days prior to the date fixed for the payment thereof.

            SECTION 3.  VOTING RIGHTS.

            The holders of shares of Series A Junior Participating Preferred
Stock shall have the following voting rights:

            (a) Subject to the provision for adjustment hereinafter set
forth, each share of Series A Junior Participating Preferred Stock shall
entitle the holder thereof to 1,000 votes on all matters submitted to a vote
of the shareholders of the Corporation. In the event the Corporation shall at
any time after the Rights Declaration Date (i) declare any dividend on Class
A Common Stock payable in shares of Class A Common Stock, (ii) subdivide the
outstanding Class A Common Stock, or (iii) combine the outstanding Class A
Common Stock into a smaller number of shares, then in each such case the
number of votes per share to which holders of shares of Series A Junior
Participating Preferred Stock were entitled immediately prior to such event
shall be adjusted by multiplying such number by a fraction the numerator of
which is the number of shares of Class A Common Stock outstanding immediately
after such event and the denominator of which is the number of shares of
Class A Common Stock that were outstanding immediately prior to such event.

            (b) Except as otherwise provided herein or by law, the holders of
shares of Series A Junior Participating Preferred Stock and the holders of
shares of Class A Common Stock and Class B Common Stock, par value $.01 per
share (the

                                     A-3
<Page>

"Class B Common Stock," and, together with the Class A Common Stock, the
"Common Stock") shall vote together as one class on all matters submitted to
a vote of shareholders of the Corporation.

            (c) (i) If at any time dividends on any Series A Junior
      Participating Preferred Stock shall be in arrears in an amount equal to
      six (6) quarterly dividends thereon, the occurrence of such contingency
      shall mark the beginning of a period (herein called a "default period")
      which shall extend until such time when all accrued and unpaid dividends
      for all previous quarterly dividend periods and for the current quarterly
      dividend period on all shares of Series A Junior Participating Preferred
      Stock then outstanding shall have been declared and paid or set apart for
      payment. During each default period, all holders of Preferred Stock
      (including holders of the Series A Junior Participating Preferred Stock)
      with dividends in arrears in an amount equal to six (6) quarterly
      dividends thereon, voting as a class, irrespective of series, shall have
      the right to elect two (2) Directors.

                  (ii) During any default period, such voting right of the
      holders of Series A Junior Participating Preferred Stock may be exercised
      initially at a special meeting called pursuant to subparagraph (iii) of
      this Section 3(c) or at any annual meeting of shareholders, and thereafter
      at annual meetings of shareholders, provided that such voting right shall
      not be exercised unless the holders of ten percent (10%) in number of
      shares of Preferred Stock outstanding shall be present in person or by
      proxy. The absence of a quorum of the holders of Common Stock shall not
      affect the exercise by the holders of Preferred Stock of such voting
      right. At any meeting at which the holders of Preferred Stock shall
      exercise such voting right initially during an existing default period,
      they shall have the right, voting as a class, to elect Directors to fill
      such vacancies, if any, in the Board of Directors as may then exist up to
      two (2) Directors or, if such right is exercised at an annual meeting, to
      elect two (2) Directors. If the number which may be so elected at any
      special meeting does not amount to the required number, the holders of the
      Preferred Stock shall have the right to make such increase in the number
      of Directors as shall be necessary to permit the election by them of the
      required number. After the holders of the Preferred Stock shall have
      exercised their right to elect Directors in any default period and during
      the continuance of such period, the number of Directors shall not be
      increased or decreased except by vote of the holders of Preferred Stock as
      herein provided or pursuant to the rights of any equity securities ranking
      senior to or PARI PASSU with the Series A Junior Participating Preferred
      Stock.

                                     A-4
<Page>

                  (iii) Unless the holders of Preferred Stock shall, during an
      existing default period, have previously exercised their right to elect
      Directors, the Board of Directors may order, or any shareholder or
      shareholders owning in the aggregate not less than ten percent (10%) of
      the total number of shares of Preferred Stock outstanding, irrespective of
      series, may request, the calling of special meeting of the holders of
      Preferred Stock, which meeting shall thereupon be called by the Chairman
      of the Board, the President, any Managing Director or the Secretary of the
      Corporation. Notice of such meeting and of any annual meeting at which
      holders of Preferred Stock are entitled to vote pursuant to this Paragraph
      (c)(iii) shall be given to each holder of record of Preferred Stock by
      mailing a copy of such notice to him or her at his or her last address as
      the same appears on the books of the Corporation. Such meeting shall be
      called for a time not earlier than 20 days and not later than 60 days
      after such order or request or in default of the calling of such meeting
      within 60 days after such order or request, such meeting may be called on
      similar notice by any shareholder or shareholders owning in the aggregate
      not less than ten percent (10%) of the total number of shares of Preferred
      Stock outstanding. Notwithstanding the provisions of this Paragraph
      (c)(iii), no such special meeting shall be called during the period within
      60 days immediately preceding the date fixed for the next annual meeting
      of the shareholders.

                  (iv) In any default period, the holders of Common Stock, and
      other classes of stock of the Corporation if applicable, shall continue to
      be entitled to elect the whole number of Directors until the holders of
      Preferred Stock shall have exercised their right to elect two (2)
      Directors voting as a class, after the exercise of which right (x) the
      Directors so elected by the holders of Preferred Stock shall continue in
      office until their successors shall have been elected by such holders or
      until the expiration of the default period, and (y) any vacancy in the
      Board of Directors may (except as provided in Paragraph (c)(ii) of this
      Section 3) be filled by vote of a majority of the remaining Directors
      theretofore elected by the holders of the class of stock which elected the
      Director whose office shall have become vacant. References in this
      Paragraph (c) to Directors elected by the holders of a particular class of
      stock shall include Directors elected by such Directors to fill vacancies
      as provided in clause (y) of the foregoing sentence.

                  (v) Immediately upon the expiration of a default period, (x)
      the right of the holders of Preferred Stock as a class to elect Directors
      shall cease, (y) the term of any Directors elected by the holders of

                                     A-5
<Page>

      Preferred Stock as a class shall terminate, and (z) the number of
      Directors shall be such number as may be provided for in the certificate
      of incorporation or by-laws irrespective of any increase made pursuant to
      the provisions of Paragraph (c)(ii) of this Section 3 (such number being
      subject, however, to change thereafter in any manner provided by law or in
      the certificate of incorporation or by-laws). Any vacancies in the Board
      of Directors effected by the provisions of clauses (y) and (z) in the
      preceding sentence may be filled by a majority of the remaining Directors.

            (d) Except as set forth herein, holders of Series A Junior
Participating Preferred Stock shall have no special voting rights and their
consent shall not be required (except to the extent they are entitled to vote
with holders of Common Stock as set forth herein) for taking any corporate
action.

            SECTION 4.  CERTAIN RESTRICTIONS.

            (a) Whenever quarterly dividends or other dividends or
distributions payable on the Series A Junior Participating Preferred Stock as
provided in Section 2 are in arrears, thereafter and until all accrued and
unpaid dividends and distributions, whether or not declared, on shares of
Series A Junior Participating Preferred Stock outstanding shall have been
paid in full, the Corporation shall not

                  (i) declare or pay dividends on, make any other distributions
      on, or redeem or purchase or otherwise acquire for consideration any
      shares of stock ranking junior (either as to dividends or upon
      liquidation, dissolution or winding up) to the Series A Junior
      Participating Preferred Stock;

                  (ii) declare or pay dividends on or make any other
      distributions on any shares of stock ranking on a parity (either as to
      dividends or upon liquidation, dissolution or winding up) with the Series
      A Junior Participating Preferred Stock, except dividends paid ratably on
      the Series A Junior Participating Preferred Stock and all such parity
      stock on which dividends are payable or in arrears in proportion to the
      total amounts to which the holders of all such shares are then entitled;

                  (iii) redeem or purchase or otherwise acquire for
      consideration shares of any stock ranking on a parity (either as to
      dividends or upon liquidation, dissolution or winding up) with the Series
      A Junior Participating Preferred Stock, provided that the Corporation may
      at any time redeem, purchase or otherwise acquire shares of any such
      parity stock in exchange for shares of any stock of the Corporation
      ranking

                                     A-6
<Page>

      junior (either as to dividends or upon dissolution, liquidation or
      winding up) to the Series A Junior Participating Preferred Stock; or

                  (iv) purchase or otherwise acquire for consideration any
      shares of Series A Junior Participating Preferred Stock, or any shares of
      stock ranking on a parity with the Series A Junior Participating Preferred
      Stock, except in accordance with a purchase offer made in writing or by
      publication (as determined by the Board of Directors) to all holders of
      such shares upon such terms as the Board of Directors, after consideration
      of the respective annual dividend rates and other relative rights and
      preferences of the respective series and classes, shall determine in good
      faith will result in fair and equitable treatment among the respective
      series or classes.

            (b) The Corporation shall not permit any subsidiary of the
Corporation to purchase or otherwise acquire for consideration any shares of
stock of the Corporation unless the Corporation could, under Paragraph (a) of
this Section 4, purchase or otherwise acquire such shares at such time and in
such manner.

            SECTION 5.  REACQUIRED SHARES.

            Any shares of Series A Junior Participating Preferred Stock
purchased or otherwise acquired by the Corporation in any manner whatsoever
shall be retired and cancelled promptly after the acquisition thereof. All
such shares shall upon their cancellation become authorized but unissued
shares of Preferred Stock and may be reissued as part of a new series of
Preferred Stock to be created by resolution or resolutions of the Board of
Directors, subject to the conditions and restrictions on issuance set forth
herein.

            SECTION 6.  LIQUIDATION, DISSOLUTION OR WINDING UP.

            (a)   Upon any liquidation (voluntary or otherwise), dissolution
or winding up of the Corporation, no distribution shall be made to the
holders of shares of stock ranking junior (either as to dividends or upon
liquidation, dissolution or winding up) to the Series A Junior Participating
Preferred Stock unless, prior thereto, the holders of shares of Series A
Junior Participating Preferred Stock shall have received an amount equal to
1,000 times the Exercise Price, plus an amount equal to accrued and unpaid
dividends and distributions thereon, whether or not declared, to the date of
such payment (the "Series A Liquidation Preference"). Following the payment
of the full amount of the Series A Liquidation Preference, no additional
distributions shall be made to the holders of shares of Series A Junior
Participating Preferred Stock unless, prior thereto, the holders of shares of
Common Stock shall

                                     A-7
<Page>

have received an amount per share (the "Common Adjustment") equal to the
quotient obtained by dividing (i) the Series A Liquidation Preference by (ii)
1,000 (as appropriately adjusted as set forth in subparagraph (c) below to
reflect such events as stock splits, stock dividends and recapitalizations
with respect to the Common Stock) (such number in clause (ii), the
"Adjustment Number"). Following the payment of the full amount of the Series
A Liquidation Preference and the Common Adjustment in respect of all
outstanding shares of Series A Junior Participating Preferred Stock and
Common Stock, respectively, holders of Series A Junior Participating
Preferred Stock and holders of shares of both classes of Common Stock shall
receive their ratable and proportionate share of the remaining assets to be
distributed in the ratio of the Adjustment Number to 1 with respect to such
Preferred Stock and Common Stock, on a per share basis, respectively.

            (b) In the event, however, that there are not sufficient assets
available to permit payment in full of the Series A Liquidation Preference
and the liquidation preferences of all other series of preferred stock, if
any, which rank on a parity with the Series A Junior Participating Preferred
Stock, then such remaining assets shall be distributed ratably to the holders
of such parity shares in proportion to their respective liquidation
preferences. In the event, however, that there are not sufficient assets
available to permit payment in full of the Common Adjustment, then such
remaining assets shall be distributed ratably to the holders of both classes
of Common Stock.

            (c) In the event the Corporation shall at any time after the
Rights Declaration Date (i) declare any dividend on Class A Common Stock
payable in shares of Class A Common Stock, (ii) subdivide the outstanding
Class A Common Stock, or (iii) combine the outstanding Class A Common Stock
into a smaller number of shares, then in each such case the Adjustment Number
in effect immediately prior to such event shall be adjusted by multiplying
such Adjustment Number by a fraction the numerator of which is the number of
shares of Class A Common Stock outstanding immediately after such event and
the denominator of which is the number of shares of Class A Common Stock that
were outstanding immediately prior to such event.

            SECTION 7.  CONSOLIDATION, MERGER, ETC.

            In case the Corporation shall enter into any consolidation,
merger, combination or other transaction in which the shares of Class A
Common Stock are exchanged for or changed into other stock or securities,
cash and/or any other property, then in any such case the shares of Series A
Junior Participating Preferred Stock shall at the same time be similarly
exchanged or changed in an amount per share (subject to the provision for
adjustment hereinafter set forth) equal to 1,000 times the

                                     A-8
<Page>

aggregate amount of stock, securities, cash and/or any other property
(payable in kind), as the case may be, into which or for which each share of
Class A Common Stock is changed or exchanged. In the event the Corporation
shall at any time after the Rights Declaration Date (i) declare any dividend
on Class A Common Stock payable in shares of Class A Common Stock, (ii)
subdivide the outstanding Class A Common Stock, or (iii) combine the
outstanding Class A Common Stock into a smaller number of shares, then in
each such case the amount set forth in the preceding sentence with respect to
the exchange or change of shares of Series A Junior Participating Preferred
Stock shall be adjusted by multiplying such amount by a fraction the
numerator of which is the number of shares of Class A Common Stock
outstanding immediately after such event and the denominator of which is the
number of shares of Class A Common Stock that were outstanding immediately
prior to such event.

            SECTION 8.  NO REDEMPTION.

            The shares of Series A Junior Participating Preferred Stock shall
not be redeemable.

            SECTION 9.  AMENDMENT.

            The Amended and Restated Certificate of Incorporation of the
Corporation shall not be further amended in any manner which would materially
alter or change the powers, preferences or special rights of the Series A
Junior Participating Preferred Stock so as to affect them adversely without
the affirmative vote of the holders of a majority or more of the outstanding
shares of Series A Junior Participating Preferred Stock, voting separately as
a class.

            SECTION 10. FRACTIONAL SHARES.

            Series A Junior Participating Preferred Stock may be issued in
fractions of a share which shall entitle the holder, in proportion to such
holders fractional shares, to exercise voting rights, receive dividends,
participate in distributions and to have the benefit of all other rights of
holders of Series A Junior Participating Preferred Stock.

                                      A-9
<Page>

           IN WITNESS WHEREOF, we have executed and subscribed this Certificate
and do affirm the foregoing as true under the penalties of perjury this __ day
of ____________, 2001.

                                      CHICAGO MERCANTILE
                                      EXCHANGE HOLDINGS INC.

                                      ----------------------------
                                      Name:
                                      Title:

Attest:

-------------------------
Secretary

                                     A-10
<Page>

                                                                       EXHIBIT B

                          [Form of Rights Certificate]

Certificate No. R-                                            ________ Rights

NOT EXERCISABLE AFTER NOVEMBER 15, 2011 OR EARLIER IF REDEEMED BY THE COMPANY.
THE RIGHTS ARE SUBJECT TO REDEMPTION, AT THE OPTION OF THE COMPANY, AT $.01 PER
RIGHT ON THE TERMS SET FORTH IN THE RIGHTS AGREEMENT. UNDER CERTAIN
CIRCUMSTANCES, RIGHTS BENEFICIALLY OWNED BY AN ACQUIRING PERSON (AS SUCH TERM IS
DEFINED IN THE RIGHTS AGREEMENT) AND ANY SUBSEQUENT HOLDER OF SUCH RIGHTS MAY
BECOME NULL AND VOID. [THE RIGHTS REPRESENTED BY THIS RIGHTS CERTIFICATE ARE OR
WERE BENEFICIALLY OWNED BY A PERSON WHO WAS OR BECAME AN ACQUIRING PERSON OR AN
AFFILIATE OR ASSOCIATE OF AN ACQUIRING PERSON (AS SUCH TERMS ARE DEFINED IN THE
RIGHTS AGREEMENT). ACCORDINGLY, THIS RIGHTS CERTIFICATE AND THE RIGHTS
REPRESENTED HEREBY MAY BECOME NULL AND VOID IN THE CIRCUMSTANCES SPECIFIED IN
SECTION 7(e) OF SUCH AGREEMENT.](1)

                               Rights Certificate

                  CHICAGO MERCANTILE EXCHANGE HOLDINGS INC.

            This certifies that _______________, or registered assigns, is the
registered owner of the number of Rights set forth above, each of which entitles
the owner thereof, subject to the terms, provisions and conditions of the Rights
Agreement, dated as of ___________, 2001 (the "Rights Agreement"), between
Chicago Mercantile Exchange Holdings Inc., a Delaware corporation (the

----------------
     (1)  The portion of the legend in brackets shall be inserted only if
          applicable and shall replace the preceding sentence.

                                     B-1
<Page>

"Company"), and Mellon Investor Services LLC, a national banking association
(the "Rights Agent"), to purchase from the Company at any time prior to 5:00
P.M. Chicago, Illinois time on November 15, 2011 at the office or offices of
the Rights Agent designated for such purpose, or its successors as Rights
Agent, one one-thousandth of a fully paid, non-assessable share of Series A
Junior Participating Preferred Stock (the "Preferred Stock") of the Company,
at a purchase price of $105 per one one-thousandth of a share (the "Purchase
Price"), upon presentation and surrender of this Rights Certificate with the
Form of Election to Purchase and related Certificate duly executed. The
number of Rights evidenced by this Rights Certificate (and the number of
shares which may be purchased upon exercise thereof) set forth above, and the
Purchase Price per share set forth above, are the number and Purchase Price
as of ___________, 2001 based on the Preferred Stock as constituted at such
date. The Company reserves the right to require prior to the occurrence of a
Triggering Event (as such term is defined in the Rights Agreement) that a
number of Rights be exercised so that only whole shares of Preferred Stock
will be issued.

            Upon the occurrence of a Section 11(a)(ii) Event (as such term is
defined in the Rights Agreement), if the Rights evidenced by this Rights
Certificate are beneficially owned by (i) an Acquiring Person or an Affiliate
or Associate of any such Acquiring Person (as such terms are defined in the
Rights Agreement), (ii) a transferee of any such Acquiring Person, Associate
or Affiliate, or (iii) under certain circumstances specified in the Rights
Agreement, a transferee of a person who, after such transfer, became an
Acquiring Person, or an Affiliate or Associate of an Acquiring Person, such
Rights shall become null and void and no holder hereof shall have any right
with respect to such Rights from and after the occurrence of such Section
11(a)(ii) Event.

            As provided in the Rights Agreement, the Purchase Price and the
number and kind of shares of Preferred Stock or other securities, which may
be purchased upon the exercise of the Rights evidenced by this Rights
Certificate are subject to modification and adjustment upon the happening of
certain events, including Triggering Events.

            This Rights Certificate is subject to all of the terms,
provisions and conditions of the Rights Agreement, which terms, provisions
and conditions are hereby incorporated herein by reference and made a part
hereof and to which Rights Agreement reference is hereby made for a full
description of the rights, limitations of rights, obligations, duties and
immunities hereunder of the Rights Agent, the Company and the holders of the
Rights Certificates, which limitations of rights include the temporary
suspension of the exercisability of such Rights under the specific
circumstances set forth in the Rights Agreement. Copies of the Rights

                                     B-2
<Page>

Agreement are on file at the above-mentioned office of the Rights Agent and
are also available upon written request to the Rights Agent.

            This Rights Certificate, with or without other Rights
Certificates, upon surrender at the principal office or offices of the Rights
Agent designated for such purpose, may be exchanged for another Rights
Certificate or Rights Certificates of like tenor and date evidencing Rights
entitling the holder to purchase a like aggregate number of one
one-thousandths of a share of Preferred Stock as the Rights evidenced by the
Rights Certificate or Rights Certificates surrendered shall have entitled
such holder to purchase. If this Rights Certificate shall be exercised in
part, the holder shall be entitled to receive upon surrender hereof another
Rights Certificate or Rights Certificates for the number of whole Rights not
exercised.

            Subject to the provisions of the Rights Agreement, the Rights
evidenced by this Rights Certificate may be redeemed by the Company at its
option at a redemption price of $.01 per Right at any time prior to the
earlier of the Close of Business on (i) the tenth day following the Stock
Acquisition Date (as such time period may be extended pursuant to the Rights
Agreement), and (ii) the Final Expiration Date. In addition, the Rights may
be exchanged, in whole or in part, for shares of the Class A Common Stock, or
shares of preferred stock of the Company having essentially the same value or
economic rights as such shares. Immediately upon the action of the Board of
Directors of the Company authorizing any such exchange, and without any
further action or any notice, the Rights (other than Rights which are not
subject to such exchange) will terminate and the Rights will only enable
holders to receive the shares issuable upon such exchange.

            No fractional shares of Preferred Stock will be issued upon the
exercise of any Right or Rights evidenced hereby (other than fractions which
are integral multiples of one one-thousandth of a share of Preferred Stock,
which may, at the election of the Company, be evidenced by depositary
receipts), but in lieu thereof a cash payment will be made, as provided in
the Rights Agreement.

            No holder of this Rights Certificate shall be entitled to vote or
receive dividends or be deemed for any purpose the holder of shares of
Preferred Stock or of any other securities of the Company which may at any
time be issuable on the exercise hereof, nor shall anything contained in the
Rights Agreement or herein be construed to confer upon the holder hereof, as
such, any of the rights of a shareholder of the Company or any right to vote
for the election of directors or upon any matter submitted to shareholders at
any meeting thereof, or to give or withhold consent to any corporate action,
or, to receive notice of meetings or other actions affecting shareholders
(except as provided in the Rights Agreement), or to receive dividends or

                                     B-3
<Page>

subscription rights, or otherwise, until the Right or Rights evidenced by
this Rights Certificate shall have been exercised as provided in the Rights
Agreement.

            This Rights Certificate shall not be valid or obligatory for any
purpose until it shall have been countersigned by the Rights Agent.

            WITNESS the facsimile signature of the proper officers of the
Company and its corporate seal.

Dated as of ____________, ____

ATTEST:                             CHICAGO MERCANTILE
                                        EXCHANGE HOLDINGS INC.

                                     By
--------------------                   --------------------
   Secretary                           Title:

Countersigned:

MELLON INVESTOR SERVICES LLC

By
  -----------------------
   Authorized Signature

                                     B-4
<Page>

                 [Form of Reverse Side of Rights Certificate]

                               FORM OF ASSIGNMENT

               (To be executed by the registered holder if such
               holder desires to transfer the Rights Certificate.)

FOR VALUE RECEIVED   _______________________________________________________
hereby sells, assigns and transfer unto ____________________________________

----------------------------------------------------------------------------
(Please print name and address of transferee)

this Rights Certificate, together with all right, title and interest therein,
and does hereby irrevocably constitute and appoint _________________ Attorney,
to transfer the within Rights Certificate on the books of the within-named
Company, with full power of substitution.

Dated: ___________________, 20__

                                          ---------------------------
                                          Signature

Signature Guaranteed:

                                   CERTIFICATE

            The undersigned hereby certifies by checking the appropriate boxes
that:

            (1) this Rights Certificate [ ] is [ ] is not being sold, assigned
and transferred by or on behalf of a Person who is or was an Acquiring Person or
an Affiliate or Associate of any such Acquiring Person (as such terms are
defined pursuant to the Rights Agreement);

                                     B-5
<Page>

            (2) after due inquiry and to the best knowledge of the undersigned,
it [ ] did [ ] did not acquire the Rights evidenced by this Rights Certificate
from any Person who is, was or subsequently became an Acquiring Person or an
Affiliate or Associate of an Acquiring Person.

Dated: __________________, 20__           ________________________
                                          Signature

Signature Guaranteed:

                                     NOTICE

            The signature to the foregoing Assignment and Certificate must
correspond to the name as written upon the face of this Rights Certificate in
every particular, without alteration or enlargement or any change whatsoever.

                                     B-6
<Page>

                          FORM OF ELECTION TO PURCHASE

                     (To be executed if holder desires to
                       exercise Rights represented by the
                             Rights Certificate.)

To: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC.:

            The undersigned hereby irrevocably elects to exercise __________
Rights represented by this Rights Certificate to purchase the shares of
Preferred Stock issuable upon the exercise of the Rights (or such other
securities of the Company or of any other person which may be issuable upon
the exercise of the Rights) and requests that certificates for such shares be
issued in the name of and delivered to:

Please insert social security
or other identifying number:
                            ------------------------------------

----------------------------------------------------------------------------
                       (Please print name and address)

----------------------------------------------------------------------------

            If such number of Rights shall not be all the Rights evidenced by
this Rights Certificate, a new Rights Certificate for the balance of such Rights
shall be registered in the name of and delivered to:

Please insert social security
or other identifying number:
                              ----------------------------------

----------------------------------------------------------------------------
                       (Please print name and address)

----------------------------------------------------------------------------

Dated:  _______________, 20__             __________________________
                                          Signature

Signature Guaranteed:

                                     B-7
<Page>

                                   CERTIFICATE

            The undersigned hereby certifies by checking the appropriate boxes
that:

            (1) the Rights evidenced by this Rights Certificate [ ] are [ ]
are not being exercised by or on behalf of a Person who is or was an
Acquiring Person or an Affiliate or Associate of any such Acquiring Person
(as such terms are defined pursuant to the Rights Agreement);

            (2) after due inquiry and to the best knowledge of the
undersigned, it [ ] did [ ] did not acquire the Rights evidenced by this
Rights Certificate from any Person who is, was or became an Acquiring Person
or an Affiliate or Associate of an Acquiring Person.

Dated: ___________, 20__                  ___________________________
                                          Signature

Signature Guaranteed:

                                     NOTICE

            The signature to the foregoing Election to Purchase and Certificate
must correspond to the name as written upon the face of this Rights Certificate
in every particular, without alteration or enlargement or any change whatsoever.

                                      B-8
<Page>

                                                                       EXHIBIT C

                          SUMMARY OF RIGHTS TO PURCHASE
                SERIES A JUNIOR PARTICIPATING PREFERRED STOCK

            On August 2, 2001, the Board of Directors of Chicago Mercantile
Exchange Holdings Inc. (the "Company") adopted a Shareholder Rights Plan,
providing that effective from and after the effective date (the "Effective
Date") of the Merger of CME Merger Subsidiary Inc. with and into Chicago
Mercantile Exchange Inc. ("CME"), whereby CME will become a wholly owned
subsidiary of the Company and the former shareholders of CME will become the
shareholders of the Company (the "Merger"), one Right shall be attached to
each share of Common Stock of the Company. Each Right entitles the registered
holder to purchase from the Company a unit (a "Unit") consisting of one
one-thousandth of a share of Series A Junior Participating Preferred Stock,
par value $.01 per share (the "Preferred Stock"), at a Purchase Price of $105
per Unit (the "Purchase Price"), subject to adjustment. The description and
terms of the Rights are set forth in the Rights Agreement (the "Rights
Agreement"), dated as of _______, 2001, between the Company and Mellon
Investor Services LLC, a national banking association, as Rights Agent (the
"Rights Agent").

            Initially, the Rights will be attached to all Common Stock
certificates representing shares then outstanding, and no separate Rights
Certificates will be distributed. The Rights will separate from the Common
Stock and a Distribution Date will occur upon the earlier of (i) 10 days
following a public announcement that a person or group of affiliated or
associated persons (an "Acquiring Person") has acquired, or obtained the
right to acquire, beneficial ownership of 15% or more of the outstanding
shares of either (a) Common Stock or (b) Class A Common Stock, other than as
a result of repurchases of stock by the Company or certain inadvertent
actions by institutional or certain other shareholders (the "Stock
Acquisition Date") or (ii) 10 Business Days following the commencement of a
tender offer or exchange offer that would result in a person or group
becoming an Acquiring Person. Until the Distribution Date, (i) the Rights
will be evidenced by the Common Stock certificates and will be transferred
with and only with such Common Stock certificates, (ii) new Common Stock
certificates issued after the Effective Date will contain a notation
incorporating the Rights Agreement by reference and (iii) the surrender for
transfer of any certificates for Common Stock outstanding will also
constitute the transfer of the Rights associated with the Common Stock
represented by such certificate.

            The Rights are not exercisable until the Distribution Date and
will expire at the Close of Business on _______, 2011, unless earlier
redeemed or exchanged by the Company as described below.

                                     C-1
<Page>

            As soon as practicable after the Distribution Date, Rights
Certificates will be mailed to holders of record of the Common Stock as of
the Close of Business on the Distribution Date and, thereafter, the separate
Rights Certificates alone will represent the Rights. Except as otherwise
determined by the Board of Directors, only shares of Common Stock outstanding
prior to the Distribution Date will be issued with Rights.

            In the event that a Person becomes an Acquiring Person (unless
such acquisition is made pursuant to a tender or exchange offer for all
outstanding shares of the Company, at a price determined by a majority of the
independent directors of the Company who are not representatives, nominees,
Affiliates or Associates of an Acquiring Person to be fair and otherwise in
the best interest of the Company and its shareholders after receiving advice
from one or more investment banking firms (a "Qualifying Offer")), each
holder of a Right will thereafter have the right to receive, upon exercise,
Class A Common Stock (or, in certain circumstances, cash, property or other
securities of the Company), having a value equal to two times the Exercise
Price of the Right. The Exercise Price is the Purchase Price times the number
of shares of Class A Common Stock associated with each Right (initially,
one). Notwithstanding any of the foregoing, following the occurrence of any
of the events set forth in this paragraph (the "Flip-In Events"), all Rights
that are, or (under certain circumstances specified in the Rights Agreement)
were, beneficially owned by any Acquiring Person will be null and void.
However, Rights are not exercisable following the occurrence of any of the
Flip-In Events set forth above until such time as the Rights are no longer
redeemable by the Company as set forth below.

            In the event that following the Stock Acquisition Date, (i) the
Company engages in a merger or business combination transaction in which the
Company is not the surviving corporation (other than a merger consummated
pursuant to a Qualifying Offer); (ii) the Company engages in a merger or
business combination transaction in which the Company is the surviving
corporation and the Common Stock of the Company is changed or exchanged; or
(iii) 50% or more of the Company's assets or earning power is sold or
transferred, each holder of a Right (except Rights which have previously been
voided as set forth above) shall thereafter have the right to receive, upon
exercise of the Right, Common Stock of the acquiring company having a value
equal to two times the Exercise Price of the Right.

            The Purchase Price payable, and the number of Units of Preferred
Stock or other securities or property issuable upon exercise of the Rights
are subject to adjustment from time to time to prevent dilution (i) in the
event of a stock dividend on, or a subdivision, combination or
reclassification of, the Preferred Stock, (ii) if holders of the Preferred
Stock are granted certain rights or warrants to subscribe for Preferred Stock
or convertible securities at less than the current market price of the

                                     C-2
<Page>

Preferred Stock, or (iii) upon the distribution to holders of the Preferred
Stock of evidences of indebtedness or assets (excluding regular quarterly
cash dividends) or of subscription rights or warrants (other than those
referred to above).

            With certain exceptions, no adjustments in the Purchase Price
will be required until cumulative adjustments amount to at least 1% of the
Purchase Price. No fractional Units will be issued and, in lieu thereof, an
adjustment in cash will be made based on the market price of the Preferred
Stock on the last trading date prior to the date of exercise.

            At any time until 10 days following the Stock Acquisition Date,
the Company may redeem the Rights in whole, but not in part, at a price of
$.01 per Right. Immediately upon the action of the Board of Directors
ordering redemption of the Rights, the Rights will terminate and the only
right of the holders of Rights will be to receive the $.01 redemption price.

            Until a Right is exercised, the holder thereof, as such, will
have no rights as a shareholder of the Company, including, without
limitation, the right to vote or to receive dividends. While the distribution
of the Rights will not be taxable to shareholders or to the Company,
shareholders may, depending upon the circumstances, recognize taxable income
in the event that the Rights become exercisable for Common Stock (or other
consideration) of the Company as set forth above.

            Any of the provisions of the Rights Agreement may be amended by
the Board of Directors of the Company prior to the Distribution Date. After
the Distribution Date, the provisions of the Rights Agreement may be amended
by the Board of Directors in order to cure any ambiguity, to correct or
supplement any defective or inconsistent provision, to make changes which do
not adversely affect the interests of holders of Rights (excluding the
interest of any Acquiring Person), or to shorten or lengthen any time period
under the Rights Agreement; PROVIDED, however, among other things, that no
amendment to adjust the time period governing redemption shall be made at
such time as the Rights are not redeemable.

            A copy of the Rights Agreement is being filed with the Securities
and Exchange Commission as an Exhibit to the Company's Registration Statement
on Form 8-A. A copy of the Rights Agreement is available free of charge from
the Company. This Summary Description of the Rights does not purport to be
complete and is qualified in its entirety by reference to the Rights
Agreement, which is incorporated herein by reference.

                                      C-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00030-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00030-of-00352.parquet"}]]